Amedeo Smart

Free Medical Literature Service


 

Amedeo

COVID-19

  Free Subscription

Articles published in
Science
    September 2022
  1. VOGEL G
    New Omicron strains may portend big COVID-19 waves.
    Science. 2022;377:1479.
    >> Share

  2. THORP HH
    Communicating with clarity.
    Science. 2022;377:1363.
    >> Share

  3. COUZIN-FRANKEL J
    Private venture tackles Long Covid, aims to test drugs soon.
    Science. 2022;377:1245.
    >> Share

  4. TEGALLY H, San JE, Cotten M, Moir M, et al
    The evolving SARS-CoV-2 epidemic in Africa: Insights from rapidly expanding genomic surveillance.
    Science. 2022 Sep 15:eabq5358. doi: 10.1126/science.abq5358.
    >> Share

  5. PIERCE CA, Herold KC, Herold BC, Chou J, et al
    COVID-19 and children.
    Science. 2022;377:1144-1149.
    >> Share

  6. MARSHALL-GRADISNIK S, Eaton-Fitch N
    Understanding myalgic encephalomyelitis.
    Science. 2022;377:1150-1151.
    >> Share

  7. RICHARDS CM, Jabs S, Qiao W, Varanese LD, et al
    The human disease gene LYSET is essential for lysosomal enzyme transport and viral infection.
    Science. 2022 Sep 8:eabn5648. doi: 10.1126/science.abn5648.
    >> Share

    August 2022
  8. JIANG X, Wang R
    Wildlife trade is likely the source of SARS-CoV-2.
    Science. 2022;377:925-926.
    >> Share

  9. CALIFF RM
    The FDA and scientific priorities.
    Science. 2022;377:905.
    >> Share

  10. WHERRY EJ, Barouch DH
    T cell immunity to COVID-19 vaccines.
    Science. 2022;377:821-822.
    >> Share

  11. COUZIN-FRANKEL J
    Long Covid clues emerge from patients' blood.
    Science. 2022;377:803.
    >> Share

  12. COHEN J
    Anywhere but here.
    Science. 2022;377:805-809.
    >> Share

  13. COHEN J
    Making broader coronavirus vaccines is a struggle.
    Science. 2022;377:566-567.
    >> Share

    July 2022
  14. WOROBEY M, Levy JI, Serrano LM, Crits-Christoph A, et al
    The Huanan Seafood Wholesale Market in Wuhan was the early epicenter of the COVID-19 pandemic.
    Science. 2022 Jul 26:abp8715. doi: 10.1126/science.abp8715.
    >> Share

  15. PEKAR JE, Magee A, Parker E, Moshiri N, et al
    The molecular epidemiology of multiple zoonotic origins of SARS-CoV-2.
    Science. 2022 Jul 26:eabp8337. doi: 10.1126/science.abp8337.
    >> Share

  16. BOWEN JE, Addetia A, Dang HV, Stewart C, et al
    Omicron spike function and neutralizing activity elicited by a comprehensive panel of vaccines.
    Science. 2022 Jul 19:eabq0203. doi: 10.1126/science.abq0203.
    >> Share

  17. WACHTER RM
    Nailing the nuance on COVID-19.
    Science. 2022;377:243.
    >> Share

  18. MITCHAM C, Nordmann A, Liu Y
    Zero-COVID Editorial lacks balance.
    Science. 2022;377:270-271.
    >> Share

  19. CHEN R, Guo X, Zhu A
    Vaccinate to combat COVID-19 in China.
    Science. 2022;377:271.
    >> Share

  20. LOW JS, Jerak J, Tortorici MA, McCallum M, et al
    ACE2-binding exposes the SARS-CoV-2 fusion peptide to broadly neutralizing coronavirus antibodies.
    Science. 2022 Jul 12:eabq2679. doi: 10.1126/science.abq2679.
    >> Share

  21. DACON C, Tucker C, Peng L, Lee CD, et al
    Broadly neutralizing antibodies target the coronavirus fusion peptide.
    Science. 2022 Jul 12:eabq3773. doi: 10.1126/science.abq3773.
    >> Share

  22. SERVICE RF
    Bad news for Paxlovid? Resistance may be coming.
    Science. 2022;377:138-139.
    >> Share

  23. COHEN AA, van Doremalen N, Greaney AJ, Andersen H, et al
    Mosaic RBD nanoparticles protect against challenge by diverse sarbecoviruses in animal models.
    Science. 2022 Jul 5:eabq0839. doi: 10.1126/science.abq0839.
    >> Share

  24. ROPER WL
    Science, health, and truth.
    Science. 2022;377:7.
    >> Share

    June 2022
  25. STARR TN, Greaney AJ, Hannon WW, Loes AN, et al
    Shifting mutational constraints in the SARS-CoV-2 receptor-binding domain during viral evolution.
    Science. 2022 Jun 28:eabo7896. doi: 10.1126/science.abo7896.
    >> Share

  26. BUCHANAN CJ, Gaunt B, Harrison PJ, Yang Y, et al
    Pathogen-sugar interactions revealed by universal saturation transfer analysis.
    Science. 2022 Jun 23:eabm3125. doi: 10.1126/science.abm3125.
    >> Share

  27. YUAN S, Ye ZW, Liang R, Tang K, et al
    Pathogenicity, transmissibility, and fitness of SARS-CoV-2 Omicron in Syrian hamsters.
    Science. 2022 Jun 23:eabn8939. doi: 10.1126/science.abn8939.
    >> Share

  28. WADMAN M
    Glacial pace for U.S. Long Covid grants.
    Science. 2022;376:1262-1263.
    >> Share

  29. REYNOLDS CJ, Pade C, Gibbons JM, Otter AD, et al
    Immune boosting by B.1.1.529 (Omicron) depends on previous SARS-CoV-2 exposure.
    Science. 2022 Jun 14:eabq1841. doi: 10.1126/science.abq1841.
    >> Share

  30. SAAD-ROY CM, Metcalf CJE, Grenfell BT
    Immuno-epidemiology and the predictability of viral evolution.
    Science. 2022;376:1161-1162.
    >> Share

  31. KIRBY WC
    Zeroing out on zero-COVID.
    Science. 2022;376:1026.
    >> Share

    May 2022
  32. WADMAN M
    Coronavirus, adenovirus, or both? Hepatitis poses mystery.
    Science. 2022;376:906-907.
    >> Share

  33. INSEL T
    Mental health care 2.0.
    Science. 2022;376:899.
    >> Share

  34. OBERMEYER F, Jankowiak M, Barkas N, Schaffner SF, et al
    Analysis of 6.4 million SARS-CoV-2 genomes identifies mutations associated with fitness.
    Science. 2022 May 24:abm1208. doi: 10.1126/science.abm1208.
    >> Share

  35. ELLIOTT P, Eales O, Steyn N, Tang D, et al
    Twin peaks: The Omicron SARS-CoV-2 BA.1 and BA.2 epidemics in England.
    Science. 2022 May 24:eabq4411. doi: 10.1126/science.abq4411.
    >> Share

  36. BRAINARD J
    'COVID-ization' of research levels off.
    Science. 2022;376:782-783.
    >> Share

  37. COHEN J
    Do you hate your face mask? There's hope.
    Science. 2022;376:783-784.
    >> Share

  38. VOGEL G
    New subvariants are masters of immune evasion.
    Science. 2022;376:679-680.
    >> Share

  39. THORP HH
    It ain't over 'til it's over.
    Science. 2022;376:675.
    >> Share

  40. ZELNER J, Eisenberg M
    Rapid response modeling of SARS-CoV-2 transmission.
    Science. 2022;376:579-580.
    >> Share

    April 2022
  41. ARINAMINPATHY N, Saad-Roy CM, Yang Q, Ahmad I, et al
    A global system for the next generation of vaccines.
    Science. 2022;376:462-464.
    >> Share

  42. NORMILE D
    China refuses to end harsh lockdowns.
    Science. 2022;376:333-334.
    >> Share

    March 2022
  43. KUCHARSKI AJ, Cohen C
    Effective surveillance of variants.
    Science. 2022;375:1349-1350.
    >> Share

  44. ASAI D, Alberts B, Coffey J
    Redo college intro science.
    Science. 2022;375:1321.
    >> Share

  45. ZHOU T, Wang L, Misasi J, Pegu A, et al
    Structural basis for potent antibody neutralization of SARS-CoV-2 variants including B.1.1.529.
    Science. 2022 Mar 24:eabn8897. doi: 10.1126/science.abn8897.
    >> Share

  46. PULLIAM JRC, van Schalkwyk C, Govender N, von Gottberg A, et al
    Increased risk of SARS-CoV-2 reinfection associated with emergence of Omicron in South Africa.
    Science. 2022 Mar 15:eabn4947. doi: 10.1126/science.abn4947.
    >> Share

  47. MERAD M, Blish CA, Sallusto F, Iwasaki A, et al
    The immunology and immunopathology of COVID-19.
    Science. 2022;375:1122-1127.
    >> Share

  48. EDWARDS AM, Baric RS, Saphire EO, Ulmer JB, et al
    Stopping pandemics before they start: Lessons learned from SARS-CoV-2.
    Science. 2022;375:1133-1139.
    >> Share

  49. DEAN NE, Halloran ME
    Protecting the herd with vaccination.
    Science. 2022;375:1088-1089.
    >> Share

  50. PAGEL C
    "Back to normal" is not enough.
    Science. 2022;375:1069.
    >> Share

  51. KOELLE K, Martin MA, Antia R, Lopman B, et al
    The changing epidemiology of SARS-CoV-2.
    Science. 2022;375:1116-1121.
    >> Share

  52. GAVRILOVIC M, Rubio M, Bastagli F, Hinton R, et al
    Gender-responsive social protection post-COVID-19.
    Science. 2022;375:1111-1113.
    >> Share

  53. MOBARAK AM, Miguel E, Abaluck J, Ahuja A, et al
    End COVID-19 in low- and middle-income countries.
    Science. 2022;375:1105-1110.
    >> Share

  54. ALTMANN DM, Boyton RJ
    COVID-19 vaccination: The road ahead.
    Science. 2022;375:1127-1132.
    >> Share

  55. HOLMES EC
    COVID-19-lessons for zoonotic disease.
    Science. 2022;375:1114-1115.
    >> Share

  56. VOGEL G
    Signals from the sewer.
    Science. 2022;375:1100-1104.
    >> Share

  57. LI J, Zaslavsky M, Su Y, Guo J, et al
    KIR(+)CD8(+) T cells suppress pathogenic T cells and are active in autoimmune diseases and COVID-19.
    Science. 2022 Mar 8:eabi9591. doi: 10.1126/science.abi9591.
    >> Share

    February 2022
  58. MCCALLUM M, Czudnochowski N, Rosen LE, Zepeda SK, et al
    Structural basis of SARS-CoV-2 Omicron immune evasion and receptor engagement.
    Science. 2022 Feb 25:eabn8652. doi: 10.1126/science.abn8652.
    >> Share

  59. BASTARD P
    Why do people die from COVID-19?
    Science. 2022;375:829-830.
    >> Share

  60. WADMAN M
    COVID-19 boosts risk of heart disease 1 year later.
    Science. 2022;375:706-707.
    >> Share

  61. ROURKE M, Eccleston-Turner M, Switzer S
    Sovereignty, sanctions, and data sharing under international law.
    Science. 2022;375:724-726.
    >> Share

  62. SERVICK K
    Scientists call 'endemic' message premature.
    Science. 2022;375:703-704.
    >> Share

  63. WADMAN M
    Lasting impact of infection extends to the brain.
    Science. 2022;375:707.
    >> Share

  64. JHA P, Deshmukh Y, Tumbe C, Suraweera W, et al
    COVID mortality in India: National survey data and health facility deaths.
    Science. 2022;375:667-671.
    >> Share

  65. KAKU CI, Champney ER, Normark J, Garcia M, et al
    Broad anti-SARS-CoV-2 antibody immunity induced by heterologous ChAdOx1/mRNA-1273 vaccination.
    Science. 2022 Feb 10:eabn2688. doi: 10.1126/science.abn2688.
    >> Share

  66. ELLIOTT P, Bodinier B, Eales O, Wang H, et al
    Rapid increase in Omicron infections in England during December 2021: REACT-1 study.
    Science. 2022 Feb 8:eabn8347. doi: 10.1126/science.abn8347.
    >> Share

  67. YIN W, Xu Y, Xu P, Cao X, et al
    Structures of the Omicron Spike trimer with ACE2 and an anti-Omicron antibody.
    Science. 2022 Feb 8:eabn8863. doi: 10.1126/science.abn8863.
    >> Share

  68. WADMAN M
    New Omicron begins to take over, despite late start.
    Science. 2022;375:480-481.
    >> Share

  69. SWANSTROM R, Schinazi RF
    Lethal mutagenesis as an antiviral strategy.
    Science. 2022;375:497-498.
    >> Share

    January 2022
  70. PARK YJ, De Marco A, Starr TN, Liu Z, et al
    Antibody-mediated broad sarbecovirus neutralization through ACE2 molecular mimicry.
    Science. 2022;375:449-454.
    >> Share

  71. KUPFERSCHMIDT K
    After Omicron, some scientists foresee 'a period of quiet'.
    Science. 2022;375:366-367.
    >> Share

  72. COUZIN-FRANKEL J, Vogel G
    Vaccines may cause rare, Long Covid-like symptoms.
    Science. 2022;375:364-366.
    >> Share

  73. HAYEK S, Shaham G, Ben-Shlomo Y, Kepten E, et al
    Indirect protection of children from SARS-CoV-2 infection through parental vaccination.
    Science. 2022 Jan 27:eabm3087. doi: 10.1126/science.abm3087.
    >> Share

  74. PRUNAS O, Warren JL, Crawford FW, Gazit S, et al
    Vaccination with BNT162b2 reduces transmission of SARS-CoV-2 to household contacts in Israel.
    Science. 2022 Jan 27:eabl4292. doi: 10.1126/science.abl4292.
    >> Share

  75. REINCKE SM, Yuan M, Kornau HC, Corman VM, et al
    SARS-CoV-2 Beta variant infection elicits potent lineage-specific and cross-reactive antibodies.
    Science. 2022 Jan 25:eabm5835. doi: 10.1126/science.abm5835.
    >> Share

  76. WADMAN M
    Studies reveal dangers of SARS-CoV-2 infection in pregnancy.
    Science. 2022;375:253.
    >> Share

  77. SPUDICH S, Nath A
    Nervous system consequences of COVID-19.
    Science. 2022;375:267-269.
    >> Share

  78. TOPOL E
    It's not too late.
    Science. 2022;375:245.
    >> Share

  79. MANNAR D, Saville JW, Zhu X, Srivastava SS, et al
    SARS-CoV-2 Omicron variant: Antibody evasion and cryo-EM structure of spike protein-ACE2 complex.
    Science. 2022 Jan 20:eabn7760. doi: 10.1126/science.abn7760.
    >> Share

  80. MUIK A, Lui BG, Wallisch AK, Bacher M, et al
    Neutralization of SARS-CoV-2 Omicron by BNT162b2 mRNA vaccine-elicited human sera.
    Science. 2022 Jan 18:eabn7591. doi: 10.1126/science.abn7591.
    >> Share

  81. COHEN J
    India's pandemic toll far exceeds official count.
    Science. 2022;375:128-129.
    >> Share

  82. KUPFERSCHMIDT K, Vogel G
    Omicron threat remains fuzzy as cases explode.
    Science. 2022;375:9-10.
    >> Share

    December 2021
  83. GUPTA RK, Topol EJ
    COVID-19 vaccine breakthrough infections.
    Science. 2021;374:1561-1562.
    >> Share

  84. JOHNSON BA, Menachery VD
    A new tool to probe SARS-CoV-2 variants.
    Science. 2021;374:1557-1558.
    >> Share

  85. THORP HH
    It's not as easy as it looks.
    Science. 2021;374:1537.
    >> Share

  86. COHEN J
    Will global vaccine shortfalls end in 2022?
    Science. 2021;374:1546.
    >> Share

  87. COHEN J
    Omicron sparks a vaccine strategy debate.
    Science. 2021;374:1544-1545.
    >> Share

  88. VOGEL G, Kupferschmidt K
    Early lab studies shed light on Omicron's behavior.
    Science. 2021;374:1543-1544.
    >> Share

  89. CERNUSCHI T, Malvolti S, Downham M, Maugeais D, et al
    COVID-19 impact on infant and adolescent vaccine supplies.
    Science. 2021;374:1438-1441.
    >> Share

  90. KUPFERSCHMIDT K
    Missed shots.
    Science. 2021;374:1434-1435.
    >> Share

  91. KUPFERSCHMIDT K
    Scientists see a 'really, really tough winter' with Omicron.
    Science. 2021;374:1421-1422.
    >> Share

  92. SCOTT L, Hsiao NY, Moyo S, Singh L, et al
    Track Omicron's spread with molecular data.
    Science. 2021;374:1454-1455.
    >> Share

  93. COUZIN-FRANKEL J
    How pandemic pressure is re-engineering clinical trials.
    Science. 2021;374:1308-1309.
    >> Share

  94. KUPFERSCHMIDT K, Vogel G
    How bad is Omicron? Some clues are emerging.
    Science. 2021;374:1304-1305.
    >> Share

  95. O'GRADY C
    Poor trials of health steps are worse than none, scientists say.
    Science. 2021;374:1180-1181.
    >> Share

  96. KUPFERSCHMIDT K
    Startling new variant raises urgent questions.
    Science. 2021;374:1178-1180.
    >> Share

  97. KUPFERSCHMIDT K
    Where did 'weird' Omicron come from?
    Science. 2021;374:1179.
    >> Share

  98. ABALUCK J, Kwong LH, Styczynski A, Haque A, et al
    Impact of community masking on COVID-19: A cluster-randomized trial in Bangladesh.
    Science. 2021 Dec 2:eabi9069.
    >> Share

  99. REYNOLDS CJ, Gibbons JM, Pade C, Lin KM, et al
    Heterologous infection and vaccination shapes immunity against SARS-CoV-2 variants.
    Science. 2021 Dec 2:eabm0811.
    >> Share

  100. SOURIMANT J, Lieber CM, Aggarwal M, Cox RM, et al
    4'-Fluorouridine is an oral antiviral that blocks respiratory syncytial virus and SARS-CoV-2 replication.
    Science. 2021 Dec 2:eabj5508.
    >> Share

  101. NABEL KG, Clark SA, Shankar S, Pan J, et al
    Structural basis for continued antibody evasion by the SARS-CoV-2 receptor binding domain.
    Science. 2021 Dec 2:eabl6251.
    >> Share

    November 2021
  102. PAI M, Olatunbosun-Alakija A
    Vax the world.
    Science. 2021;374:1031.
    >> Share

  103. RANDOLPH HE, Fiege JK, Thielen BK, Mickelson CK, et al
    Genetic ancestry effects on the response to viral infection are pervasive but cell type specific.
    Science. 2021;374:1127-1133.
    >> Share

  104. GILBERT PB, Montefiori DC, McDermott AB, Fong Y, et al
    Immune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy clinical trial.
    Science. 2021 Nov 23:eab3435.
    >> Share

  105. CHYBA CF, Cassel CK, Graham SL, Holdren JP, et al
    Create a COVID-19 commission.
    Science. 2021;374:932-935.
    >> Share

  106. GERBER JS, Offit PA
    COVID-19 vaccines for children.
    Science. 2021;374:913.
    >> Share

  107. NORMILE D
    'Zero COVID' is getting harder-but China is sticking with it.
    Science. 2021;374:924.
    >> Share

  108. WOROBEY M
    Dissecting the early COVID-19 cases in Wuhan.
    Science. 2021 Nov 18:eabm4454.
    >> Share

  109. JECKER NS
    Cash incentives, ethics, and COVID-19 vaccination.
    Science. 2021;374:819-820.
    >> Share

  110. THORP HH
    Self-inflicted wounds.
    Science. 2021;374:793.
    >> Share

  111. COUZIN-FRANKEL J
    Antiviral pills could change pandemic's course.
    Science. 2021;374:799-800.
    >> Share

  112. PIETZNER M, Wheeler E, Carrasco-Zanini J, Cortes A, et al
    Mapping the proteo-genomic convergence of human diseases.
    Science. 2021;374:eabj1541.
    >> Share

  113. MCCALLUM M, Walls AC, Sprouse KR, Bowen JE, et al
    Molecular basis of immune evasion by the Delta and Kappa SARS-CoV-2 variants.
    Science. 2021 Nov 9:eabl8506. doi: 10.1126/science.abl8506.
    >> Share

  114. LADHANI SN
    Children and COVID-19 in schools.
    Science. 2021;374:680-682.
    >> Share

  115. PROCTOR EK, Geng E
    A new lane for science.
    Science. 2021;374:659.
    >> Share

  116. COHN BA, Cirillo PM, Murphy CC, Krigbaum NY, et al
    SARS-CoV-2 vaccine protection and deaths among US veterans during 2021.
    Science. 2021 Nov 4:eabm0620. doi: 10.1126/science.abm0620.
    >> Share

  117. SYED AM, Taha TY, Tabata T, Chen IP, et al
    Rapid assessment of SARS-CoV-2 evolved variants using virus-like particles.
    Science. 2021 Nov 4:eabl6184. doi: 10.1126/science.abl6184.
    >> Share

  118. ELLIOTT P, Haw D, Wang H, Eales O, et al
    Exponential growth, high prevalence of SARS-CoV-2, and vaccine effectiveness associated with the Delta variant.
    Science. 2021 Nov 2:eabl9551. doi: 10.1126/science.abl9551.
    >> Share

  119. OWEN DR, Allerton CMN, Anderson AS, Aschenbrenner L, et al
    An oral SARS-CoV-2 M(pro) inhibitor clinical candidate for the treatment of COVID-19.
    Science. 2021 Nov 2:eabl4784. doi: 10.1126/science.abl4784.
    >> Share

    October 2021
  120. SCHOGGINS J
    Defective viral RNA sensing linked to severe COVID-19.
    Science. 2021;374:535-536.
    >> Share

  121. ZHANG J, Xiao T, Cai Y, Lavine CL, et al
    Membrane fusion and immune evasion by the spike protein of SARS-CoV-2 Delta variant.
    Science. 2021 Oct 26:eabl9463. doi: 10.1126/science.abl9463.
    >> Share

  122. KRISHTEL P, Hassan F
    Share vaccine know-how.
    Science. 2021;374:379.
    >> Share

  123. COHEN J
    What tore apart The Lancet's COVID-19 origin probe?
    Science. 2021;374:387-388.
    >> Share

  124. WILKINSON E, Giovanetti M, Tegally H, San JE, et al
    A year of genomic surveillance reveals how the SARS-CoV-2 pandemic unfolded in Africa.
    Science. 2021;374:423-431.
    >> Share

  125. PAGEL C, Yates CA
    Tackling the pandemic with (biased) data.
    Science. 2021;374:403-404.
    >> Share

  126. CORBETT KS, Gagne M, Wagner DA, O' Connell S, et al
    Protection against SARS-CoV-2 beta variant in mRNA-1273 vaccine-boosted nonhuman primates.
    Science. 2021 Oct 21:eabl8912. doi: 10.1126/science.abl8912.
    >> Share

  127. RICARDO-LAX I, Luna JM, Thao TTN, Le Pen J, et al
    Replication and single-cycle delivery of SARS-CoV-2 replicons.
    Science. 2021 Oct 14:eabj8430. doi: 10.1126/science.abj8430.
    >> Share

  128. DHAR MS, Marwal R, Vs R, Ponnusamy K, et al
    Genomic characterization and epidemiology of an emerging SARS-CoV-2 variant in Delhi, India.
    Science. 2021 Oct 14:eabj9932. doi: 10.1126/science.abj9932.
    >> Share

  129. GOEL RR, Painter MM, Apostolidis SA, Mathew D, et al
    mRNA vaccines induce durable immune memory to SARS-CoV-2 and variants of concern.
    Science. 2021 Oct 14:eabm0829. doi: 10.1126/science.abm0829.
    >> Share

  130. VAN KERKHOVE MD, Ryan MJ, Ghebreyesus TA
    Preparing for "Disease X".
    Science. 2021 Oct 13:eabm7796. doi: 10.1126/science.abm7796.
    >> Share

  131. KUPFERSCHMIDT K
    Pandemic enters transition phase-but to what?
    Science. 2021;374:135-136.
    >> Share

  132. BRAND SPC, Ojal J, Aziza R, Were V, et al
    COVID-19 transmission dynamics underlying epidemic waves in Kenya.
    Science. 2021 Oct 7:eabk0414. doi: 10.1126/science.abk0414.
    >> Share

  133. CAMPOS-MERCADE P, Meier AN, Schneider FH, Meier S, et al
    Monetary incentives increase COVID-19 vaccinations.
    Science. 2021 Oct 7:eabm0475. doi: 10.1126/science.abm0475.
    >> Share

  134. COHEN J
    New Chinese vaccine could bolster global arsenal.
    Science. 2021;374:12-13.
    >> Share

  135. YANNIER N, Hudson SE, Koedinger KR, Hirsh-Pasek K, et al
    Active learning: "Hands-on" meets "minds-on".
    Science. 2021;374:26-30.
    >> Share

    September 2021
  136. WICKENHAGEN A, Sugrue E, Lytras S, Kuchi S, et al
    A prenylated dsRNA sensor protects against severe COVID-19.
    Science. 2021 Sep 28:eabj3624. doi: 10.1126/science.abj3624.
    >> Share

  137. KAISER J
    Large study will probe Long Covid.
    Science. 2021;373:1429.
    >> Share

  138. WADMAN M
    Israel's high case plateau may offer worrisome portent.
    Science. 2021;373:1428-1429.
    >> Share

  139. HASTIE KM, Li H, Bedinger D, Schendel SL, et al
    Defining variant-resistant epitopes targeted by SARS-CoV-2 antibodies: A global consortium study.
    Science. 2021 Sep 23:eabh2315. doi: 10.1126/science.abh2315.
    >> Share

  140. CORBETT KS, Nason MC, Flach B, Gagne M, et al
    Immune correlates of protection by mRNA-1273 vaccine against SARS-CoV-2 in nonhuman primates.
    Science. 2021;373:eabj0299.
    >> Share

  141. MATEUS J, Dan JM, Zhang Z, Rydyznski Moderbacher C, et al
    Low-dose mRNA-1273 COVID-19 vaccine generates durable memory enhanced by cross-reactive T cells.
    Science. 2021 Sep 14:eabj9853. doi: 10.1126/science.abj9853.
    >> Share

  142. WADMAN M
    U.S. ups coronavirus surveillance.
    Science. 2021;373:1184.
    >> Share

  143. BRAINARD J
    A COVID-19 publishing revolution? Not yet.
    Science. 2021;373:1182-1183.
    >> Share

  144. HASLAM SA
    Leveraging the collective mindThe Power of Us Jay J. Van Bavel and Dominic J. Packer Little, Brown Spark, 2021. 320 pp.
    Science. 2021;373:1206.
    >> Share

  145. COHEN J
    The hunt for SARS-CoV-2's ancestors heats up.
    Science. 2021;373:1076-1077.
    >> Share

  146. WADMAN M
    SARS-CoV-2 infection confers greater immunity than shots.
    Science. 2021;373:1067-1068.
    >> Share

  147. COHEN J
    Call of the wild.
    Science. 2021;373:1072-1077.
    >> Share

    August 2021
  148. LOYAL L, Braun J, Henze L, Kruse B, et al
    Cross-reactive CD4(+) T cells enhance SARS-CoV-2 immune responses upon infection and vaccination.
    Science. 2021 Aug 31. pii: science.abh1823. doi: 10.1126/science.abh1823.
    >> Share

  149. WANG CC, Prather KA, Sznitman J, Jimenez JL, et al
    Airborne transmission of respiratory viruses.
    Science. 2021;373.
    >> Share

  150. KUPFERSCHMIDT K
    Do chronic infections breed dangerous new variants?
    Science. 2021;373:848.
    >> Share

  151. KUPFERSCHMIDT K
    Evolving threat.
    Science. 2021;373:844-849.
    >> Share

  152. WADMAN M
    Israel's grim warning: Delta can overwhelm shots.
    Science. 2021;373:838-839.
    >> Share

  153. WAGNER CE, Saad-Roy CM, Morris SE, Baker RE, et al
    Vaccine nationalism and the dynamics and control of SARS-CoV-2.
    Science. 2021 Aug 17. pii: science.abj7364. doi: 10.1126/science.abj7364.
    >> Share

  154. LYTRAS S, Xia W, Hughes J, Jiang X, et al
    The animal origin of SARS-CoV-2.
    Science. 2021 Aug 17. pii: science.abh0117. doi: 10.1126/science.abh0117.
    >> Share

  155. PEGU A, O'Connell S, Schmidt SD, O'Dell S, et al
    Durability of mRNA-1273 vaccine-induced antibodies against SARS-CoV-2 variants.
    Science. 2021 Aug 12. pii: science.abj4176. doi: 10.1126/science.abj4176.
    >> Share

  156. KUPFERSCHMIDT K
    WHO relaunches global drug trial with three new candidates.
    Science. 2021;373:606-607.
    >> Share

  157. PINTO D, Sauer MM, Czudnochowski N, Low JS, et al
    Broad betacoronavirus neutralization by a stem helix-specific human antibody.
    Science. 2021 Aug 3. pii: science.abj3321. doi: 10.1126/science.abj3321.
    >> Share

    July 2021
  158. TUMMINO TA, Rezelj VV, Fischer B, Fischer A, et al
    Drug-induced phospholipidosis confounds drug repurposing for SARS-CoV-2.
    Science. 2021;373:541-547.
    >> Share

  159. EDWARDS A, Hartung IV
    No shortcuts to SARS-CoV-2 antivirals.
    Science. 2021;373:488-489.
    >> Share

  160. ALWAN NA
    The road to addressing Long Covid.
    Science. 2021;373:491-493.
    >> Share

  161. WADMAN M
    The overlooked superpower of mRNA vaccines.
    Science. 2021;373:479.
    >> Share

  162. LIU C, Shi W, Becker ST, Schatz DG, et al
    Structural basis of mismatch recognition by a SARS-CoV-2 proofreading enzyme.
    Science. 2021 Jul 27. pii: science.abi9310. doi: 10.1126/science.abi9310.
    >> Share

  163. LUND FE, Randall TD
    Scent of a vaccine.
    Science. 2021;373:397-399.
    >> Share

  164. KRAEMER MUG, Hill V, Ruis C, Dellicour S, et al
    Spatiotemporal invasion dynamics of SARS-CoV-2 lineage B.1.1.7 emergence.
    Science. 2021 Jul 22. pii: science.abj0113. doi: 10.1126/science.abj0113.
    >> Share

  165. DRAYMAN N, DeMarco JK, Jones KA, Azizi SA, et al
    Masitinib is a broad coronavirus 3CL inhibitor that blocks replication of SARS-CoV-2.
    Science. 2021 Jul 20. pii: science.abg5827. doi: 10.1126/science.abg5827.
    >> Share

  166. COUZIN-FRANKEL J
    Will COVID-19 change science? Past pandemics offer clues.
    Science. 2021;373:264-265.
    >> Share

  167. POIRIER EZ, Buck MD, Chakravarty P, Carvalho J, et al
    An isoform of Dicer protects mammalian stem cells against multiple RNA viruses.
    Science. 2021;373:231-236.
    >> Share

  168. CEVIK M, Baral SD
    Networks of SARS-CoV-2 transmission.
    Science. 2021;373:162-163.
    >> Share

  169. WADMAN M
    Journal retracts paper claiming COVID-19 vaccines kill.
    Science. 2021;373:147.
    >> Share

  170. O'GRADY C
    Sex and gender missing in COVID-19 data.
    Science. 2021;373:145.
    >> Share

  171. COHEN J
    Can immune responses predict which vaccines work best?
    Science. 2021;373:142-143.
    >> Share

  172. COHEN J
    Did a Chinese team 'obscure' early coronavirus sequences?
    Science. 2021;373:15.
    >> Share

  173. MCCALLUM M, Bassi J, De Marco A, Chen A, et al
    SARS-CoV-2 immune evasion by the B.1.427/B.1.429 variant of concern.
    Science. 2021 Jul 1. pii: science.abi7994. doi: 10.1126/science.abi7994.
    >> Share

  174. WANG L, Zhou T, Zhang Y, Yang ES, et al
    Ultrapotent antibodies against diverse and highly transmissible SARS-CoV-2 variants.
    Science. 2021 Jul 1. pii: science.abh1766. doi: 10.1126/science.abh1766.
    >> Share

    June 2021
  175. GOBEIL SM, Janowska K, McDowell S, Mansouri K, et al
    Effect of natural mutations of SARS-CoV-2 on spike structure, conformation, and antigenicity.
    Science. 2021 Jun 24. pii: science.abi6226. doi: 10.1126/science.abi6226.
    >> Share

  176. CAI Y, Zhang J, Xiao T, Lavine CL, et al
    Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants.
    Science. 2021 Jun 24. pii: science.abi9745. doi: 10.1126/science.abi9745.
    >> Share

  177. MARTINEZ DR, Schafer A, Leist SR, De la Cruz G, et al
    Chimeric spike mRNA vaccines protect against Sarbecovirus challenge in mice.
    Science. 2021 Jun 22. pii: science.abi4506. doi: 10.1126/science.abi4506.
    >> Share

  178. KAISER J
    DNA test to predict odds of severe COVID-19 draws scrutiny.
    Science. 2021;372:1139.
    >> Share

  179. VOGEL G
    Mixing vaccines may boost immune responses.
    Science. 2021;372:1138.
    >> Share

  180. COHEN J
    'Landmark' African vaccine trial faces impasse.
    Science. 2021;372:1135-1136.
    >> Share

  181. CAMELL CD, Yousefzadeh MJ, Zhu Y, Langhi Prata LGP, et al
    Senolytics reduce coronavirus-related mortality in old mice.
    Science. 2021 Jun 8. pii: science.abe4832. doi: 10.1126/science.abe4832.
    >> Share

  182. GOMEZ GB, Mahe C, Chaves SS
    Uncertain effects of the pandemic on respiratory viruses.
    Science. 2021;372:1043-1044.
    >> Share

  183. HAY JA, Kennedy-Shaffer L, Kanjilal S, Lennon NJ, et al
    Estimating epidemiologic dynamics from cross-sectional viral load distributions.
    Science. 2021 Jun 3. pii: science.abh0635. doi: 10.1126/science.abh0635.
    >> Share

  184. MAIO N, Lafont BAP, Sil D, Li Y, et al
    Fe-S cofactors in the SARS-CoV-2 RNA-dependent RNA polymerase are potential antiviral targets.
    Science. 2021 Jun 3. pii: science.abi5224. doi: 10.1126/science.abi5224.
    >> Share

    May 2021
  185. KING A
    Two more coronaviruses may infect people.
    Science. 2021;372:893.
    >> Share

  186. JONES TC, Biele G, Muhlemann B, Veith T, et al
    Estimating infectiousness throughout SARS-CoV-2 infection course.
    Science. 2021 May 25. pii: science.abi5273. doi: 10.1126/science.abi5273.
    >> Share

  187. WADMAN M
    Blind spots thwart global coronavirus tracking.
    Science. 2021;372:773-774.
    >> Share

  188. CHENG Y, Ma N, Witt C, Rapp S, et al
    Face masks effectively limit the probability of SARS-CoV-2 transmission.
    Science. 2021 May 20. pii: science.abg6296. doi: 10.1126/science.abg6296.
    >> Share

  189. YUAN M, Huang D, Lee CD, Wu NC, et al
    Structural and functional ramifications of antigenic drift in recent SARS-CoV-2 variants.
    Science. 2021 May 20. pii: science.abh1139. doi: 10.1126/science.abh1139.
    >> Share

  190. LOW JS, Vaqueirinho D, Mele F, Foglierini M, et al
    Clonal analysis of immunodominance and cross-reactivity of the CD4 T cell response to SARS-CoV-2.
    Science. 2021 May 18. pii: science.abg8985. doi: 10.1126/science.abg8985.
    >> Share

  191. BLOOM JD, Chan YA, Baric RS, Bjorkman PJ, et al
    Investigate the origins of COVID-19.
    Science. 2021;372:694.
    >> Share

  192. COHEN J
    Do coronavirus genes slip into human chromosomes?
    Science. 2021;372:674-675.
    >> Share

  193. BALICER RD, Ohana R
    Israel's COVID-19 endgame.
    Science. 2021;372:663.
    >> Share

  194. BHATT PR, Scaiola A, Loughran G, Leibundgut M, et al
    Structural basis of ribosomal frameshifting during translation of the SARS-CoV-2 RNA genome.
    Science. 2021 May 13. pii: science.abf3546. doi: 10.1126/science.abf3546.
    >> Share

  195. GARCIA-FINANA M, Buchan IE
    Rapid antigen testing in COVID-19 responses.
    Science. 2021;372:571-572.
    >> Share

  196. COHEN J
    Is India's coronavirus death 'paradox' vanishing?
    Science. 2021;372:552-553.
    >> Share

  197. VOSS WN, Hou YJ, Johnson NV, Delidakis G, et al
    Prevalent, protective, and convergent IgG recognition of SARS-CoV-2 non-RBD spike epitopes.
    Science. 2021 May 4. pii: science.abg5268. doi: 10.1126/science.abg5268.
    >> Share

    April 2021
  198. REYNOLDS CJ, Pade C, Gibbons JM, Butler DK, et al
    Prior SARS-CoV-2 infection rescues B and T cell responses to variants after first vaccine dose.
    Science. 2021 Apr 30. pii: science.abh1282. doi: 10.1126/science.abh1282.
    >> Share

  199. CHOE H, Farzan M
    How SARS-CoV-2 first adapted in humans.
    Science. 2021;372:466-467.
    >> Share

  200. COUZIN-FRANKEL J
    Relief and worry for immune-suppressed people.
    Science. 2021;372:443-444.
    >> Share

  201. LESSLER J, Grabowski MK, Grantz KH, Badillo-Goicoechea E, et al
    Household COVID-19 risk and in-person schooling.
    Science. 2021 Apr 29. pii: science.abh2939. doi: 10.1126/science.abh2939.
    >> Share

  202. MENA GE, Martinez PP, Mahmud AS, Marquet PA, et al
    Socioeconomic status determines COVID-19 incidence and related mortality in Santiago, Chile.
    Science. 2021 Apr 27. pii: science.abg5298. doi: 10.1126/science.abg5298.
    >> Share

  203. JIAO C, Sharma S, Dugar G, Peeck NL, et al
    Noncanonical crRNAs derived from host transcripts enable multiplexable RNA detection by Cas9.
    Science. 2021 Apr 27. pii: science.abe7106. doi: 10.1126/science.abe7106.
    >> Share

  204. SAAD-ROY CM, Morris SE, Metcalf CJE, Mina MJ, et al
    Partial immunity and SARS-CoV-2 mutations-Response.
    Science. 2021;372:354-355.
    >> Share

  205. HANAGE WP, Russell CA
    Partial immunity and SARS-CoV-2 mutations.
    Science. 2021;372:354.
    >> Share

  206. RILEY S, Ainslie KEC, Eales O, Walters CE, et al
    Resurgence of SARS-CoV-2: detection by community viral surveillance.
    Science. 2021 Apr 23. pii: science.abf0874. doi: 10.1126/science.abf0874.
    >> Share

  207. COHEN J
    The dream vaccine.
    Science. 2021;372:227-231.
    >> Share

  208. KUPFERSCHMIDT K, Vogel G
    Vaccine link to serious clotting disorder firms up.
    Science. 2021;372:220-221.
    >> Share

  209. CASTRO MC, Kim S, Barberia L, Ribeiro AF, et al
    Spatiotemporal pattern of COVID-19 spread in Brazil.
    Science. 2021 Apr 14. pii: science.abh1558. doi: 10.1126/science.abh1558.
    >> Share

  210. FARIA NR, Mellan TA, Whittaker C, Claro IM, et al
    Genomics and epidemiology of the P.1 SARS-CoV-2 lineage in Manaus, Brazil.
    Science. 2021 Apr 14. pii: science.abh2644. doi: 10.1126/science.abh2644.
    >> Share

  211. YANG F, Nielsen SCA, Hoh RA, Roltgen K, et al
    Shared B cell memory to coronaviruses and other pathogens varies in human age groups and tissues.
    Science. 2021 Apr 12. pii: science.abf6648. doi: 10.1126/science.abf6648.
    >> Share

  212. DOBROVIDOVA O
    Latest Russian vaccine comes with a big dose of mystery.
    Science. 2021;372:116-117.
    >> Share

  213. FAUCI AS
    The story behind COVID-19 vaccines.
    Science. 2021;372:109.
    >> Share

  214. GUNTHER S, Reinke PYA, Fernandez-Garcia Y, Lieske J, et al
    X-ray screening identifies active site and allosteric inhibitors of SARS-CoV-2 main protease.
    Science. 2021 Apr 2. pii: science.abf7945. doi: 10.1126/science.abf7945.
    >> Share

  215. DIVINE R, Dang HV, Ueda G, Fallas JA, et al
    Designed proteins assemble antibodies into modular nanocages.
    Science. 2021;372.
    >> Share

    March 2021
  216. MCCORMICK KD, Jacobs JL, Mellors JW
    The emerging plasticity of SARS-CoV-2.
    Science. 2021;371:1306-1308.
    >> Share

  217. VOGEL G, Kupferschmidt K
    New problems erode confidence in AstraZeneca's vaccine.
    Science. 2021;371:1294-1295.
    >> Share

  218. LARSON HJ, Broniatowski DA
    Volatility of vaccine confidence.
    Science. 2021;371:1289.
    >> Share

  219. STAMATATOS L, Czartoski J, Wan YH, Homad LJ, et al
    mRNA vaccination boosts cross-variant neutralizing antibodies elicited by SARS-CoV-2 infection.
    Science. 2021 Mar 25. pii: science.abg9175. doi: 10.1126/science.abg9175.
    >> Share

  220. PAVELKA M, Van-Zandvoort K, Abbott S, Sherratt K, et al
    The impact of population-wide rapid antigen testing on SARS-CoV-2 prevalence in Slovakia.
    Science. 2021 Mar 23. pii: science.abf9648. doi: 10.1126/science.abf9648.
    >> Share

  221. ABDOOL KARIM SS, de Oliveira T, Loots G
    Appropriate names for COVID-19 variants.
    Science. 2021;371:1215.
    >> Share

  222. RASMUSSEN AL, Popescu SV
    SARS-CoV-2 transmission without symptoms.
    Science. 2021;371:1206-1207.
    >> Share

  223. DYE C, Mills MC
    COVID-19 vaccination passports.
    Science. 2021;371:1184.
    >> Share

  224. SERVICK K, Couzin-Frankel J, Matacic C
    Medicine's longest year.
    Science. 2021;371:1195-1199.
    >> Share

  225. COUZIN-FRANKEL J
    Studies chase clues to immune syndrome in kids.
    Science. 2021;371:1191-1192.
    >> Share

  226. PEKAR J, Worobey M, Moshiri N, Scheffler K, et al
    Timing the SARS-CoV-2 index case in Hubei province.
    Science. 2021 Mar 18. pii: science.abf8003. doi: 10.1126/science.abf8003.
    >> Share

  227. ZHANG J, Cai Y, Xiao T, Lu J, et al
    Structural impact on SARS-CoV-2 spike protein by D614G substitution.
    Science. 2021 Mar 16. pii: science.abf2303. doi: 10.1126/science.abf2303.
    >> Share

  228. LUCHSINGER LL, Hillyer CD
    Vaccine efficacy probable against COVID-19 variants.
    Science. 2021;371:1116.
    >> Share

  229. ALTMANN DM, Boyton RJ, Beale R
    Immunity to SARS-CoV-2 variants of concern.
    Science. 2021;371:1103-1104.
    >> Share

  230. WADMAN M
    Coronavirus sequence trove sparks frustration.
    Science. 2021;371:1086-1087.
    >> Share

  231. COLLINS FS
    COVID-19 lessons for research.
    Science. 2021;371:1081.
    >> Share

  232. SERVICE RF
    A call to arms.
    Science. 2021;371:1092-1095.
    >> Share

  233. COHEN J, Kupferschmidt K
    As vaccine surpluses loom, donation plans urged.
    Science. 2021;371:1087-1088.
    >> Share

  234. LYTHGOE KA, Hall M, Ferretti L, de Cesare M, et al
    SARS-CoV-2 within-host diversity and transmission.
    Science. 2021 Mar 9. pii: science.abg0821. doi: 10.1126/science.abg0821.
    >> Share

  235. SAAD-ROY CM, Morris SE, Metcalf CJE, Mina MJ, et al
    Epidemiological and evolutionary considerations of SARS-CoV-2 vaccine dosing regimes.
    Science. 2021 Mar 9. pii: science.abg8663. doi: 10.1126/science.abg8663.
    >> Share

  236. STOCKMAIER S, Stroeymeyt N, Shattuck EC, Hawley DM, et al
    Infectious diseases and social distancing in nature.
    Science. 2021;371.
    >> Share

  237. KUPFERSCHMIDT K
    WHO's treatment megatrial is at a standstill.
    Science. 2021;371:972-973.
    >> Share

  238. DAVIES NG, Abbott S, Barnard RC, Jarvis CI, et al
    Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England.
    Science. 2021 Mar 3. pii: science.abg3055. doi: 10.1126/science.abg3055.
    >> Share

    February 2021
  239. WONG JP, Damania B
    SARS-CoV-2 dependence on host pathways.
    Science. 2021;371:884-885.
    >> Share

  240. COUZIN-FRANKEL J
    Vaccine trials ramp up in children and adolescents.
    Science. 2021;371:874-875.
    >> Share

  241. CASTILLO JC, Ahuja A, Athey S, Baker A, et al
    Market design to accelerate COVID-19 vaccine supply.
    Science. 2021 Feb 25. pii: science.abg0889. doi: 10.1126/science.abg0889.
    >> Share

  242. KOFF WC, Berkley SF
    A universal coronavirus vaccine.
    Science. 2021;371:759.
    >> Share

  243. COHEN J
    The long road.
    Science. 2021;371:768-772.
    >> Share

  244. QIAO J, Li YS, Zeng R, Liu FL, et al
    SARS-CoV-2 M(pro) inhibitors with antiviral activity in a transgenic mouse model.
    Science. 2021 Feb 18. pii: science.abf1611. doi: 10.1126/science.abf1611.
    >> Share

  245. DE VRIES RD, Schmitz KS, Bovier FT, Predella C, et al
    Intranasal fusion inhibitory lipopeptide prevents direct-contact SARS-CoV-2 transmission in ferrets.
    Science. 2021 Feb 17. pii: science.abf4896. doi: 10.1126/science.abf4896.
    >> Share

  246. NELSON MI
    Tracking the UK SARS-CoV-2 outbreak.
    Science. 2021;371:680-681.
    >> Share

  247. SAELENS X, Schepens B
    Single-domain antibodies make a difference.
    Science. 2021;371:681-682.
    >> Share

  248. LANGIN K
    Pandemic hit academic mothers hard, data show.
    Science. 2021;371:660.
    >> Share

  249. WADMAN M
    United States rushes to fill void in viral sequencing.
    Science. 2021;371:657-658.
    >> Share

  250. ALIZON S
    Superspreading genomes.
    Science. 2021;371:574-575.
    >> Share

  251. KUPFERSCHMIDT K
    Danish scientists see tough times ahead as variant rises.
    Science. 2021;371:549-550.
    >> Share

  252. COHEN J
    Two new vaccines deliver good and bad news for the pandemic.
    Science. 2021;371:548-549.
    >> Share

  253. MCCARTHY KR, Rennick LJ, Nambulli S, Robinson-McCarthy LR, et al
    Recurrent deletions in the SARS-CoV-2 spike glycoprotein drive antibody escape.
    Science. 2021 Feb 3. pii: science.abf6950. doi: 10.1126/science.abf6950.
    >> Share

  254. MONOD M, Blenkinsop A, Xi X, Hebert D, et al
    Age groups that sustain resurging COVID-19 epidemics in the United States.
    Science. 2021 Feb 2. pii: science.abe8372. doi: 10.1126/science.abe8372.
    >> Share

    January 2021
  255. MUIK A, Wallisch AK, Sanger B, Swanson KA, et al
    Neutralization of SARS-CoV-2 lineage B.1.1.7 pseudovirus by BNT162b2 vaccine-elicited human sera.
    Science. 2021 Jan 29. pii: science.abg6105. doi: 10.1126/science.abg6105.
    >> Share

  256. MARTIN MA, VanInsberghe D, Koelle K
    Insights from SARS-CoV-2 sequences.
    Science. 2021;371:466-467.
    >> Share

  257. LU J, Guo J
    Disinfection spreads antimicrobial resistance.
    Science. 2021;371:474.
    >> Share

  258. GALANTI M, Pei S, Yamana TK, Angulo FJ, et al
    Social distancing remains key during vaccinations.
    Science. 2021;371:473-474.
    >> Share

  259. HOPE JL, Bradley LM
    Lessons in antiviral immunity.
    Science. 2021;371:464-465.
    >> Share

  260. COHEN J
    Ex-vaccine chief reflects on triumphs, failures, and Trump.
    Science. 2021;371:449-450.
    >> Share

  261. KUPFERSCHMIDT K
    Vaccinemakers ponder how to adapt to virus variants.
    Science. 2021;371:448-449.
    >> Share

  262. STARR TN, Greaney AJ, Addetia A, Hannon WW, et al
    Prospective mapping of viral mutations that escape antibodies used to treat COVID-19.
    Science. 2021 Jan 25. pii: science.abf9302. doi: 10.1126/science.abf9302.
    >> Share

  263. RAPPAZZO CG, Tse LV, Kaku CI, Wrapp D, et al
    Broad and potent activity against SARS-like viruses by an engineered human monoclonal antibody.
    Science. 2021 Jan 25. pii: science.abf4830. doi: 10.1126/science.abf4830.
    >> Share

  264. WHITE KM, Rosales R, Yildiz S, Kehrer T, et al
    Plitidepsin has potent preclinical efficacy against SARS-CoV-2 by targeting the host protein eEF1A.
    Science. 2021 Jan 25. pii: science.abf4058. doi: 10.1126/science.abf4058.
    >> Share

  265. PILLER C
    Disgraced COVID-19 studies are still routinely cited.
    Science. 2021;371:331-332.
    >> Share

  266. TAKAHASHI T, Iwasaki A
    Sex differences in immune responses.
    Science. 2021;371:347-348.
    >> Share

  267. KUPFERSCHMIDT K
    New mutations raise specter of 'immune escape'.
    Science. 2021;371:329-330.
    >> Share

  268. LESHNER AI
    Target student mental well-being.
    Science. 2021;371:325.
    >> Share

  269. BUBAR KM, Reinholt K, Kissler SM, Lipsitch M, et al
    Model-informed COVID-19 vaccine prioritization strategies by age and serostatus.
    Science. 2021 Jan 21. pii: science.abe6959. doi: 10.1126/science.abe6959.
    >> Share

  270. FITZPATRICK MC, Galvani AP
    Optimizing age-specific vaccination.
    Science. 2021 Jan 21. pii: science.abg2334. doi: 10.1126/science.abg2334.
    >> Share

  271. HIE B, Zhong ED, Berger B, Bryson B, et al
    Learning the language of viral evolution and escape.
    Science. 2021;371:284-288.
    >> Share

  272. ROBINSON-MCCARTHY LR, Mijalis AJ, Filsinger GT, de Puig H, et al
    Anomalous COVID-19 tests hinder researchers.
    Science. 2021;371:244-245.
    >> Share

  273. SERVICK K
    COVID-19 measures also suppress flu-for now.
    Science. 2021;371:224.
    >> Share

  274. SRIDHAR D, Gurdasani D
    Herd immunity by infection is not an option.
    Science. 2021;371:230-231.
    >> Share

  275. THEKEN KN, FitzGerald GA
    Bioactive lipids in antiviral immunity.
    Science. 2021;371:237-238.
    >> Share


  276. Q&A: How to market vaccination.
    Science. 2021;371:223.
    >> Share

  277. NORMILE D
    Pandemic could mark 'turning point' for Chinese science.
    Science. 2021;371:222-223.
    >> Share

  278. THORP HH
    Public debate is good for science.
    Science. 2021;371:213.
    >> Share

  279. KOENIG PA, Das H, Liu H, Kummerer BM, et al
    Structure-guided multivalent nanobodies block SARS-CoV-2 infection and suppress mutational escape.
    Science. 2021 Jan 12. pii: science.abe6230. doi: 10.1126/science.abe6230.
    >> Share

  280. LAVINE JS, Bjornstad ON, Antia R
    Immunological characteristics govern the transition of COVID-19 to endemicity.
    Science. 2021 Jan 12. pii: science.abe6522. doi: 10.1126/science.abe6522.
    >> Share

  281. COHEN AA, Gnanapragasam PNP, Lee YE, Hoffman PR, et al
    Mosaic nanoparticles elicit cross-reactive immune responses to zoonotic coronaviruses in mice.
    Science. 2021 Jan 12. pii: science.abf6840. doi: 10.1126/science.abf6840.
    >> Share

  282. DU PLESSIS L, McCrone JT, Zarebski AE, Hill V, et al
    Establishment and lineage dynamics of the SARS-CoV-2 epidemic in the UK.
    Science. 2021 Jan 8. pii: science.abf2946. doi: 10.1126/science.abf2946.
    >> Share

  283. MINA MJ, Andersen KG
    COVID-19 testing: One size does not fit all.
    Science. 2021;371:126-127.
    >> Share

  284. ZHOU P, Shi ZL
    SARS-CoV-2 spillover events.
    Science. 2021;371:120-122.
    >> Share

  285. YIN Y, Gao J, Jones BF, Wang D, et al
    Coevolution of policy and science during the pandemic.
    Science. 2021;371:128-130.
    >> Share

  286. COHEN J
    Dosing debates, transparency issues roil vaccine rollouts.
    Science. 2021;371:109-110.
    >> Share

  287. KUPFERSCHMIDT K
    Viral evolution may herald new pandemic phase.
    Science. 2021;371:108-109.
    >> Share

  288. DAN JM, Mateus J, Kato Y, Hastie KM, et al
    Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection.
    Science. 2021 Jan 6. pii: science.abf4063. doi: 10.1126/science.abf4063.
    >> Share

  289. MAEDA JM, Nkengasong JN
    The puzzle of the COVID-19 pandemic in Africa.
    Science. 2021;371:27-28.
    >> Share

  290. ADDAI BW, Ngwa W
    COVID-19 and cancer in Africa.
    Science. 2021;371:25-27.
    >> Share

  291. NORDLING L
    A health economist confronts Kenya's pandemic.
    Science. 2021;371:12-13.
    >> Share

  292. DE VRIEZE J
    Pfizer's vaccine raises allergy concerns.
    Science. 2021;371:10-11.
    >> Share

  293. KUPFERSCHMIDT K
    Fast-spreading U.K. virus variant raises alarms.
    Science. 2021;371:9-10.
    >> Share

    December 2020
  294. LARSEN MD, de Graaf EL, Sonneveld ME, Plomp HR, et al
    Afucosylated IgG characterizes enveloped viral responses and correlates with COVID-19 severity.
    Science. 2020 Dec 23. pii: science.abc8378. doi: 10.1126/science.abc8378.
    >> Share

  295. WADMAN M
    People with Down syndrome face high risk from coronavirus.
    Science. 2020;370:1384-1385.
    >> Share

  296. NORMILE D, Huihui B, Hicks L, Langin K, et al
    Ones we've lost.
    Science. 2020;370:1398-1401.
    >> Share

  297. KUPFERSCHMIDT K
    A divisive disease.
    Science. 2020;370:1395-1397.
    >> Share

  298. COHEN J
    Shots of hope.
    Science. 2020;370:1392-1394.
    >> Share

  299. SERVICK K
    mRNA's next challenge: Will it work as a drug?
    Science. 2020;370:1388-1389.
    >> Share

  300. COHEN J, Kupferschmidt K
    As vaccines emerge, a global waiting game begins.
    Science. 2020;370:1385-1387.
    >> Share

  301. THORP HH
    A breakthrough for us all.
    Science. 2020;370:1381.
    >> Share

  302. BRAUNER JM, Mindermann S, Sharma M, Johnston D, et al
    Inferring the effectiveness of government interventions against COVID-19.
    Science. 2020 Dec 15. pii: science.abd9338. doi: 10.1126/science.abd9338.
    >> Share

  303. ORTEGA RP
    Mexico's controversial coronavirus czar.
    Science. 2020;370:1261-1262.
    >> Share

  304. PATTON AH, Lawrance MF, Margres MJ, Kozakiewicz CP, et al
    A transmissible cancer shifts from emergence to endemism in Tasmanian devils.
    Science. 2020;370.
    >> Share

  305. GUTHMILLER JJ, Wilson PC
    Remembering seasonal coronaviruses.
    Science. 2020;370:1272-1273.
    >> Share

  306. COHEN J
    China's vaccine gambit.
    Science. 2020;370:1263-1267.
    >> Share

  307. THORP HH
    An opportunity to improve innovation.
    Science. 2020;370:1251.
    >> Share

  308. LEMIEUX JE, Siddle KJ, Shaw BM, Loreth C, et al
    Phylogenetic analysis of SARS-CoV-2 in Boston highlights the impact of superspreading events.
    Science. 2020 Dec 10. pii: science.abe3261. doi: 10.1126/science.abe3261.
    >> Share

  309. BUSS LF, Prete CA Jr, Abrahim CMM, Mendrone A Jr, et al
    Three-quarters attack rate of SARS-CoV-2 in the Brazilian Amazon during a largely unmitigated epidemic.
    Science. 2020 Dec 8. pii: science.abe9728. doi: 10.1126/science.abe9728.
    >> Share

  310. COHEN J
    Amid the cheering, some vaccines face questions.
    Science. 2020;370:1151.
    >> Share

  311. CORNWALL W
    New challenges emerge for planned human challenge trials.
    Science. 2020;370:1150.
    >> Share

  312. PILLER C
    Federal hospital data system falters at tracking pandemic.
    Science. 2020;370:1148-1149.
    >> Share

  313. WENDLER D, Ochoa J, Millum J, Grady C, et al
    COVID-19 vaccine trial ethics once we have efficacious vaccines.
    Science. 2020 Dec 3. pii: science.abf5084. doi: 10.1126/science.abf5084.
    >> Share

    November 2020
  314. PRESS WH, Levin RC
    Modeling, post COVID-19.
    Science. 2020;370:1015.
    >> Share

  315. VOGEL G, Couzin-Frankel J
    Grade: incomplete.
    Science. 2020;370:1023-1027.
    >> Share

  316. WADMAN M
    Public needs to prep for vaccine side effects.
    Science. 2020;370:1022.
    >> Share

  317. BRINI E, Simmerling C, Dill K
    Protein storytelling through physics.
    Science. 2020;370.
    >> Share

  318. SUN K, Wang W, Gao L, Wang Y, et al
    Transmission heterogeneities, kinetics, and controllability of SARS-CoV-2.
    Science. 2020 Nov 24. pii: science.abe2424. doi: 10.1126/science.abe2424.
    >> Share

  319. COHEN J
    Vaccine wagers on coronavirus surface protein pay off.
    Science. 2020;370:894-895.
    >> Share

  320. GUPTA R
    Advancing new tools for infectious diseases.
    Science. 2020;370:913-914.
    >> Share

  321. DE VRIEZE J
    Reinfections, still rare, provide clues on immunity.
    Science. 2020;370:895-897.
    >> Share

  322. KNIPE DM, Levy O, Fitzgerald KA, Muhlberger E, et al
    Ensuring vaccine safety.
    Science. 2020 Nov 17. pii: science.abf0357. doi: 10.1126/science.abf0357.
    >> Share

  323. KIELIAN M
    Enhancing host cell infection by SARS-CoV-2.
    Science. 2020;370:765-766.
    >> Share

  324. BLASIMME A, Vayena E
    What's next for COVID-19 apps? Governance and oversight.
    Science. 2020;370:760-762.
    >> Share

  325. CHANDRASHEKHAR V
    India's COVID-19 teacher.
    Science. 2020;370:752-753.
    >> Share

  326. LESTE-LASSERRE C
    Pandemic dooms Danish mink-and mink research.
    Science. 2020;370:754.
    >> Share

  327. WADMAN M, Cornwall W
    To tackle pandemic, Biden must overcome distrust and division.
    Science. 2020;370:750-751.
    >> Share

  328. COHEN J
    Effective vaccine offers shot of hope for pandemic.
    Science. 2020;370:748-749.
    >> Share

  329. TUCKSON RV
    The disease of distrust.
    Science. 2020;370:745.
    >> Share

  330. HOU YJ, Chiba S, Halfmann P, Ehre C, et al
    SARS-CoV-2 D614G variant exhibits efficient replication ex vivo and transmission in vivo.
    Science. 2020 Nov 12. pii: science.abe8499. doi: 10.1126/science.abe8499.
    >> Share

  331. UYOGA S, Adetifa IMO, Karanja HK, Nyagwange J, et al
    Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Kenyan blood donors.
    Science. 2020 Nov 11. pii: science.abe1916. doi: 10.1126/science.abe1916.
    >> Share

  332. OUDE MUNNINK BB, Sikkema RS, Nieuwenhuijse DF, Molenaar RJ, et al
    Transmission of SARS-CoV-2 on mink farms between humans and mink and back to humans.
    Science. 2020 Nov 10. pii: science.abe5901. doi: 10.1126/science.abe5901.
    >> Share

  333. NG KW, Faulkner N, Cornish GH, Rosa A, et al
    Preexisting and de novo humoral immunity to SARS-CoV-2 in humans.
    Science. 2020 Nov 6. pii: science.abe1107. doi: 10.1126/science.abe1107.
    >> Share

  334. LAXMINARAYAN R, Wahl B, Dudala SR, Gopal K, et al
    Epidemiology and transmission dynamics of COVID-19 in two Indian states.
    Science. 2020;370:691-697.
    >> Share

  335. WADMAN M
    'Nothing is impossible,' says lab ace Nita Patel.
    Science. 2020;370:652.
    >> Share

  336. WADMAN M
    The long shot.
    Science. 2020;370:649-653.
    >> Share

  337. KUPFERSCHMIDT K
    Europe is locking down again-but its strategy is unclear.
    Science. 2020;370:644-645.
    >> Share

  338. COHEN J, Kupferschmidt K
    'A very, very bad look' for remdesivir.
    Science. 2020;370:642-643.
    >> Share

  339. THORP HH
    Gradually, then suddenly.
    Science. 2020;370:639.
    >> Share

  340. XIANG Y, Nambulli S, Xiao Z, Liu H, et al
    Versatile and multivalent nanobodies efficiently neutralize SARS-CoV-2.
    Science. 2020 Nov 5. pii: science.abe4747. doi: 10.1126/science.abe4747.
    >> Share

  341. LINSKY TW, Vergara R, Codina N, Nelson JW, et al
    De novo design of potent and resilient hACE2 decoys to neutralize SARS-CoV-2.
    Science. 2020 Nov 5. pii: science.abe0075. doi: 10.1126/science.abe0075.
    >> Share

  342. SCHOOF M, Faust B, Saunders RA, Sangwan S, et al
    An ultrapotent synthetic nanobody neutralizes SARS-CoV-2 by stabilizing inactive Spike.
    Science. 2020 Nov 5. pii: science.abe3255. doi: 10.1126/science.abe3255.
    >> Share

    October 2020
  343. CROW MM, Alger J, Amiridis M, Assanis D, et al
    Support U.S. research during COVID-19.
    Science. 2020;370:539-540.
    >> Share

  344. COUZIN-FRANKEL J
    How an immunologist pivoted to tackle COVID-19.
    Science. 2020;370:514-515.
    >> Share

  345. HALFWERK W
    The quiet spring of 2020.
    Science. 2020;370:523-524.
    >> Share

  346. XIA C, Lam SS, Sonne C
    Ban unsustainable mink production.
    Science. 2020;370:539.
    >> Share

  347. CHANDRASHEKHAR V
    Herd immunity? India still has a long way to go, scientists say.
    Science. 2020;370:513.
    >> Share

  348. WAJNBERG A, Amanat F, Firpo A, Altman DR, et al
    Robust neutralizing antibodies to SARS-CoV-2 infection persist for months.
    Science. 2020 Oct 28. pii: science.abd7728. doi: 10.1126/science.abd7728.
    >> Share

  349. LEE EC, Wada NI, Grabowski MK, Gurley ES, et al
    The engines of SARS-CoV-2 spread.
    Science. 2020;370:406-407.
    >> Share

  350. BECK DB, Aksentijevich I
    Susceptibility to severe COVID-19.
    Science. 2020;370:404-405.
    >> Share

  351. PILLER C
    How CDC foundered.
    Science. 2020;370:396.
    >> Share

  352. PILLER C
    Undermining CDC.
    Science. 2020;370:394-399.
    >> Share

  353. COHEN J
    First vaccine may stymie hunt for better ones.
    Science. 2020;370:389-390.
    >> Share

  354. KUPFERSCHMIDT K
    Global trial eliminates drugs, pivots to new ones.
    Science. 2020;370:388-389.
    >> Share

  355. LIPSITCH M, Dean NE
    Understanding COVID-19 vaccine efficacy.
    Science. 2020 Oct 21. pii: science.abe5938. doi: 10.1126/science.abe5938.
    >> Share

  356. BANGARU S, Ozorowski G, Turner HL, Antanasijevic A, et al
    Structural analysis of full-length SARS-CoV-2 spike protein from an advanced vaccine candidate.
    Science. 2020 Oct 20. pii: science.abe1502. doi: 10.1126/science.abe1502.
    >> Share

  357. DALY JL, Simonetti B, Klein K, Chen KE, et al
    Neuropilin-1 is a host factor for SARS-CoV-2 infection.
    Science. 2020 Oct 20. pii: science.abd3072. doi: 10.1126/science.abd3072.
    >> Share

  358. CANTUTI-CASTELVETRI L, Ojha R, Pedro LD, Djannatian M, et al
    Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity.
    Science. 2020 Oct 20. pii: science.abd2985. doi: 10.1126/science.abd2985.
    >> Share

  359. ANDRIJEVIC M, Schleussner CF, Gidden MJ, McCollum DL, et al
    COVID-19 recovery funds dwarf clean energy investment needs.
    Science. 2020;370:298-300.
    >> Share

  360. KAISER J
    Found: genes that sway the course of the coronavirus.
    Science. 2020;370:275-276.
    >> Share

  361. MERVIS J
    Weathering the storm.
    Science. 2020;370:278-282.
    >> Share

  362. SHELL ER
    The United Kingdom's mask crusader.
    Science. 2020;370:276-277.
    >> Share

  363. LANGIN K
    U.S. faculty job market tanks.
    Science. 2020;370:272-273.
    >> Share

  364. THORP HH
    Not throwing away our shot.
    Science. 2020;370:266.
    >> Share

  365. GORDON DE, Hiatt J, Bouhaddou M, Rezelj VV, et al
    Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms.
    Science. 2020 Oct 15. pii: science.abe9403. doi: 10.1126/science.abe9403.
    >> Share

  366. SHAMAN J, Galanti M
    Will SARS-CoV-2 become endemic?
    Science. 2020 Oct 14. pii: science.abe5960. doi: 10.1126/science.abe5960.
    >> Share

  367. WELLS AI, Coyne CB
    Inhibiting Ebola virus and SARS-CoV-2 entry.
    Science. 2020;370:167-168.
    >> Share

  368. BAUM A, Ajithdoss D, Copin R, Zhou A, et al
    REGN-COV2 antibodies prevent and treat SARS-CoV-2 infection in rhesus macaques and hamsters.
    Science. 2020 Oct 9. pii: science.abe2402. doi: 10.1126/science.abe2402.
    >> Share

  369. RAMOS SE
    A pandemic journey.
    Science. 2020;370:258.
    >> Share

  370. STREICKER DG, Gilbert AT
    Contextualizing bats as viral reservoirs.
    Science. 2020;370:172-173.
    >> Share

  371. VOGEL G
    Sweden's gamble.
    Science. 2020;370:159-163.
    >> Share

  372. COHEN J
    A call to test new vaccines head to head, in monkeys.
    Science. 2020;370:154-155.
    >> Share

  373. RAVEN PH, Miller SE
    Here today, gone tomorrow.
    Science. 2020;370:149.
    >> Share

  374. THORP HH
    Words matter.
    Science. 2020;370.
    >> Share

  375. PRATHER KA, Marr LC, Schooley RT, McDiarmid MA, et al
    Airborne transmission of SARS-CoV-2.
    Science. 2020 Oct 5. pii: science.abf0521. doi: 10.1126/science.abf0521.
    >> Share

  376. KUPFERSCHMIDT K
    The 'bat man' tackles COVID-19.
    Science. 2020;370:20-21.
    >> Share

  377. BOVENBERG J, Peloquin D, Bierer B, Barnes M, et al
    How to fix the GDPR's frustration of global biomedical research.
    Science. 2020;370:40-42.
    >> Share

  378. SERVICE RF
    A call for diagnostic tests to report viral load.
    Science. 2020;370:22.
    >> Share

    September 2020
  379. SHROCK E, Fujimura E, Kula T, Timms RT, et al
    Viral epitope profiling of COVID-19 patients reveals cross-reactivity and correlates of severity.
    Science. 2020 Sep 29. pii: science.abd4250. doi: 10.1126/science.abd4250.
    >> Share

  380. GUERRINI CJ, Sherkow JS, Meyer MN, Zettler PJ, et al
    Self-experimentation, ethics, and regulation of vaccines.
    Science. 2020;369:1570-1572.
    >> Share

  381. JACK JC, Gonet J, Mease A, Nowak K, et al
    Traditional Knowledge underlies One Health.
    Science. 2020;369:1576.
    >> Share

  382. MCTIGHE K
    Turkey targets critics of its pandemic response.
    Science. 2020;369:1554.
    >> Share

  383. KUPFERSCHMIDT K
    Despite obstacles, WHO unveils plan to distribute vaccine.
    Science. 2020;369:1553.
    >> Share

  384. WADE L
    Fighting to be counted.
    Science. 2020;369:1551-1552.
    >> Share

  385. WADMAN M
    Flawed interferon response spurs severe illness.
    Science. 2020;369:1550-1551.
    >> Share

  386. BASTARD P, Rosen LB, Zhang Q, Michailidis E, et al
    Auto-antibodies against type I IFNs in patients with life-threatening COVID-19.
    Science. 2020 Sep 24. pii: science.abd4585. doi: 10.1126/science.abd4585.
    >> Share

  387. ZHANG Q, Bastard P, Liu Z, Le Pen J, et al
    Inborn errors of type I IFN immunity in patients with life-threatening COVID-19.
    Science. 2020 Sep 24. pii: science.abd4570. doi: 10.1126/science.abd4570.
    >> Share

  388. TORTORICI MA, Beltramello M, Lempp FA, Pinto D, et al
    Ultrapotent human antibodies protect against SARS-CoV-2 challenge via multiple mechanisms.
    Science. 2020 Sep 24. pii: science.abe3354. doi: 10.1126/science.abe3354.
    >> Share

  389. DERRYBERRY EP, Phillips JN, Derryberry GE, Blum MJ, et al
    Singing in a silent spring: Birds respond to a half-century soundscape reversion during the COVID-19 shutdown.
    Science. 2020 Sep 24. pii: science.abd5777. doi: 10.1126/science.abd5777.
    >> Share

  390. TOPOL EJ
    COVID-19 can affect the heart.
    Science. 2020 Sep 23. pii: science.abe2813. doi: 10.1126/science.abe2813.
    >> Share

  391. SNAPE MD, Viner RM
    COVID-19 in children and young people.
    Science. 2020 Sep 21. pii: science.abd6165. doi: 10.1126/science.abd6165.
    >> Share

  392. SAAD-ROY CM, Wagner CE, Baker RE, Morris SE, et al
    Immune life history, vaccination, and the dynamics of SARS-CoV-2 over the next 5 years.
    Science. 2020 Sep 21. pii: science.abd7343. doi: 10.1126/science.abd7343.
    >> Share

  393. TOELZER C, Gupta K, Yadav SKN, Borucu U, et al
    Free fatty acid binding pocket in the locked structure of SARS-CoV-2 spike protein.
    Science. 2020 Sep 21. pii: science.abd3255. doi: 10.1126/science.abd3255.
    >> Share

  394. VENDITTO VJ, Hudspeth B, Freeman PR, Kebodeaux C, et al
    University-pharmacy partnerships for COVID-19.
    Science. 2020;369:1441.
    >> Share

  395. CHANDRASHEKHAR V
    The burden of stigma.
    Science. 2020;369:1419-1423.
    >> Share

  396. COUZIN-FRANKEL J
    Viral heart damage under scrutiny.
    Science. 2020;369:1414-1415.
    >> Share

  397. SERVICK K
    Pandemic inspires push to shrink jails, prisons.
    Science. 2020;369:1412-1413.
    >> Share

  398. THORP HH
    Trump lied about science.
    Science. 2020;369:1409.
    >> Share

  399. ADYEL TM
    Accumulation of plastic waste during COVID-19.
    Science. 2020;369:1314-1315.
    >> Share

  400. UNCHWANIWALA N, Ahlquist P
    Coronavirus dons a new crown.
    Science. 2020;369:1306-1307.
    >> Share

  401. WADMAN M
    Why obesity worsens COVID-19.
    Science. 2020;369:1280-1281.
    >> Share

  402. DENOLLE MA, Nissen-Meyer T
    Quiet Anthropocene, quiet Earth.
    Science. 2020;369:1299-1300.
    >> Share

  403. YUDELL M, Roberts D, DeSalle R, Tishkoff S, et al
    NIH must confront the use of race in science.
    Science. 2020;369:1313-1314.
    >> Share

  404. SERVICK K
    Speaking science to power.
    Science. 2020;369:1282-1283.
    >> Share

  405. BEDFORD T, Greninger AL, Roychoudhury P, Starita LM, et al
    Cryptic transmission of SARS-CoV-2 in Washington state.
    Science. 2020 Sep 10. pii: science.abc0523. doi: 10.1126/science.abc0523.
    >> Share

  406. WOROBEY M, Pekar J, Larsen BB, Nelson MI, et al
    The emergence of SARS-CoV-2 in Europe and North America.
    Science. 2020 Sep 10. pii: science.abc8169. doi: 10.1126/science.abc8169.
    >> Share

  407. CAO L, Goreshnik I, Coventry B, Case JB, et al
    De novo design of picomolar SARS-CoV-2 miniprotein inhibitors.
    Science. 2020 Sep 9. pii: science.abd9909. doi: 10.1126/science.abd9909.
    >> Share

  408. TURNEY S, Carvalho MM, Sousa ME, Birrer C, et al
    Support transgender scientists post-COVID-19.
    Science. 2020;369:1171-1172.
    >> Share

  409. DEKOSKY BJ
    A molecular trap against COVID-19.
    Science. 2020;369:1167-1168.
    >> Share

  410. LORDAN R, FitzGerald GA, Grosser T
    Reopening schools during COVID-19.
    Science. 2020;369:1146.
    >> Share

  411. KUPFERSCHMIDT K
    Can Europe tame the pandemic's next wave?
    Science. 2020;369:1151-1152.
    >> Share

  412. EMANUEL EJ, Persad G, Kern A, Buchanan A, et al
    An ethical framework for global vaccine allocation.
    Science. 2020 Sep 3. pii: science.abe2803. doi: 10.1126/science.abe2803.
    >> Share

    August 2020
  413. SERVICE RF
    Spit shines for easier coronavirus testing.
    Science. 2020;369:1041-1042.
    >> Share

  414. AGRAWAL A
    Bridging digital health divides.
    Science. 2020;369:1050-1052.
    >> Share

  415. STARR D
    How Italy's 'father of the swabs' fought the virus.
    Science. 2020;369:1040-1041.
    >> Share

  416. WADMAN M
    Critics slam NIH for demands on bat grant targeted by Trump.
    Science. 2020;369:1039.
    >> Share

  417. KUPFERSCHMIDT K, Cohen J
    In plasma OK, critics see politics, not science.
    Science. 2020;369:1038-1039.
    >> Share

  418. CAPLAN AL, Bateman-House A
    The danger of DIY vaccines.
    Science. 2020;369:1035.
    >> Share

  419. BRUCHEZ A, Sha K, Johnson J, Chen L, et al
    MHC class II transactivator CIITA induces cell resistance to Ebola virus and SARS-like coronaviruses.
    Science. 2020 Aug 27. pii: science.abb3753. doi: 10.1126/science.abb3753.
    >> Share

  420. SERVICK K
    Coronavirus creates a flu season guessing game.
    Science. 2020;369:890-891.
    >> Share

  421. YANG H, Ma M, Thompson JR, Flower RJ, et al
    Protect the giant ibis through the pandemic.
    Science. 2020;369:929.
    >> Share

  422. STOKSTAD E
    Pandemic lockdown stirs up ecological research.
    Science. 2020;369:893.
    >> Share

  423. ROBERTS L
    Pandemic's fallout on malaria control appears limited so far.
    Science. 2020;369:892.
    >> Share

  424. TURONOVA B, Sikora M, Schurmann C, Hagen WJH, et al
    In situ structural analysis of SARS-CoV-2 spike reveals flexibility mediated by three hinges.
    Science. 2020 Aug 18. pii: science.abd5223. doi: 10.1126/science.abd5223.
    >> Share

  425. BHARTI N
    Controlling the coronavirus narrative.
    Science. 2020;369:780.
    >> Share

  426. PEREZ-ESCOBAR OA, Richardson JE, Howes MR, Lucas E, et al
    Untapped resources for medical research.
    Science. 2020;369:781-782.
    >> Share

  427. NORDLING L
    Africa's pandemic puzzle: why so few cases and deaths?
    Science. 2020;369:756-757.
    >> Share

  428. BAZELL R
    Looking for the light in Haiti.
    Science. 2020;369:755-756.
    >> Share

  429. ORTEGA RP, Wessel L
    For science in Latin America, 'a fascinating challenge'.
    Science. 2020;369:753-754.
    >> Share

  430. COHEN J
    Antibodies may curb pandemic before vaccines.
    Science. 2020;369:752-753.
    >> Share

  431. FIDLER DP
    Vaccine nationalism's politics.
    Science. 2020;369:749.
    >> Share

  432. THORP HH
    A dangerous rush for vaccines.
    Science. 2020 Aug 13. pii: science.abe3147. doi: 10.1126/science.abe3147.
    >> Share

  433. PRICE WN 2ND, Rai AK, Minssen T
    Knowledge transfer for large-scale vaccine manufacturing.
    Science. 2020 Aug 13. pii: science.abc9588. doi: 10.1126/science.abc9588.
    >> Share

  434. ARUNACHALAM PS, Wimmers F, Mok CKP, Perera RAPM, et al
    Systems biological assessment of immunity to mild versus severe COVID-19 infection in humans.
    Science. 2020 Aug 11. pii: science.abc6261. doi: 10.1126/science.abc6261.
    >> Share

  435. MBOW M, Lell B, Jochems SP, Cisse B, et al
    COVID-19 in Africa: Dampening the storm?
    Science. 2020;369:624-626.
    >> Share

  436. WADMAN M
    COVID-19 unlikely to cause birth defects, but doctors await fall births.
    Science. 2020;369:607.
    >> Share

  437. DE OLIVEIRA G, Chen JM, Stark SC, Berenguer E, et al
    Smoke pollution's impacts in Amazonia.
    Science. 2020;369:634-635.
    >> Share

  438. COUZIN-FRANKEL J
    The long haul.
    Science. 2020;369:614-617.
    >> Share

  439. LANGIN K
    Pandemic hits scientist parents hard.
    Science. 2020;369:609-610.
    >> Share

  440. SERVICE RF
    Fast, cheap tests could enable safer reopening.
    Science. 2020;369:608-609.
    >> Share

  441. WADMAN M
    Why infection poses a special risk to pregnant women.
    Science. 2020;369:606-607.
    >> Share

  442. COLLINS C
    Productivity in a pandemic.
    Science. 2020;369:603.
    >> Share

  443. WOLFF G, Limpens RWAL, Zevenhoven-Dobbe JC, Laugks U, et al
    A molecular pore spans the double membrane of the coronavirus replication organelle.
    Science. 2020 Aug 6. pii: science.abd3629. doi: 10.1126/science.abd3629.
    >> Share

  444. MATEUS J, Grifoni A, Tarke A, Sidney J, et al
    Selective and cross-reactive SARS-CoV-2 T cell epitopes in unexposed humans.
    Science. 2020 Aug 4. pii: science.abd3871. doi: 10.1126/science.abd3871.
    >> Share

  445. CHAN KK, Dorosky D, Sharma P, Abbasi SA, et al
    Engineering human ACE2 to optimize binding to the spike protein of SARS coronavirus 2.
    Science. 2020 Aug 4. pii: science.abc0870. doi: 10.1126/science.abc0870.
    >> Share

    July 2020
  446. MCCLEERY RA, Fletcher RJ Jr, Kruger LM, Govender D, et al
    Conservation needs a COVID-19 bailout.
    Science. 2020;369:515-516.
    >> Share

  447. MATHESON NJ, Lehner PJ
    How does SARS-CoV-2 cause COVID-19?
    Science. 2020;369:510-511.
    >> Share

  448. LABORDE D, Martin W, Swinnen J, Vos R, et al
    COVID-19 risks to global food security.
    Science. 2020;369:500-502.
    >> Share

  449. COHEN J
    Wuhan coronavirus hunter Shi Zhengli speaks out.
    Science. 2020;369:487-488.
    >> Share

  450. TRASK A, Canessa S, Moehrenschlager A, Newland S, et al
    Extinct-in-the-wild species' last stand.
    Science. 2020;369:516.
    >> Share

  451. KUPFERSCHMIDT K
    Global plan seeks to promote vaccine equity, spread risks.
    Science. 2020;369:489-490.
    >> Share

  452. THORP HH
    Cautious optimism.
    Science. 2020;369:483.
    >> Share

  453. GU H, Chen Q, Yang G, He L, et al
    Adaptation of SARS-CoV-2 in BALB/c mice for testing vaccine efficacy.
    Science. 2020 Jul 30. pii: science.abc4730. doi: 10.1126/science.abc4730.
    >> Share

  454. ARTELLE KA, Brown K, Chan DE, Silver JJ, et al
    A community-led approach to COVID-19.
    Science. 2020;369:385-386.
    >> Share

  455. HUETE-PEREZ J, Hildebrand J
    Nicaragua's COVID-19 crisis demands a response.
    Science. 2020;369:385.
    >> Share

  456. AASSVE A, Cavalli N, Mencarini L, Plach S, et al
    The COVID-19 pandemic and human fertility.
    Science. 2020;369:370-371.
    >> Share

  457. METCALF CJE, Morris DH, Park SW
    Mathematical models to guide pandemic response.
    Science. 2020;369:368-369.
    >> Share

  458. ABDOOL KARIM Q, Abdool Karim SS
    COVID-19 affects HIV and tuberculosis care.
    Science. 2020;369:366-368.
    >> Share

  459. ROBERTS L
    Polio vaccinators are back after pandemic pause.
    Science. 2020;369:360.
    >> Share

  460. PILLER C
    Data secrecy may cripple U.S. attempts to slow pandemic.
    Science. 2020;369:356-358.
    >> Share

  461. CANDIDO DS, Claro IM, de Jesus JG, Souza WM, et al
    Evolution and epidemic spread of SARS-CoV-2 in Brazil.
    Science. 2020 Jul 23. pii: science.abd2161. doi: 10.1126/science.abd2161.
    >> Share

  462. LV Z, Deng YQ, Ye Q, Cao L, et al
    Structural basis for neutralization of SARS-CoV-2 and SARS-CoV by a potent therapeutic antibody.
    Science. 2020 Jul 23. pii: science.abc5881. doi: 10.1126/science.abc5881.
    >> Share

  463. LECOCQ T, Hicks SP, Van Noten K, van Wijk K, et al
    Global quieting of high-frequency seismic noise due to COVID-19 pandemic lockdown measures.
    Science. 2020 Jul 23. pii: science.abd2438. doi: 10.1126/science.abd2438.
    >> Share

  464. HSIEH CL, Goldsmith JA, Schaub JM, DiVenere AM, et al
    Structure-based design of prefusion-stabilized SARS-CoV-2 spikes.
    Science. 2020 Jul 23. pii: science.abd0826. doi: 10.1126/science.abd0826.
    >> Share

  465. CAI Y, Zhang J, Xiao T, Peng H, et al
    Distinct conformational states of SARS-CoV-2 spike protein.
    Science. 2020 Jul 21. pii: science.abd4251. doi: 10.1126/science.abd4251.
    >> Share

  466. ALI ST, Wang L, Lau EHY, Xu XK, et al
    Serial interval of SARS-CoV-2 was shortened over time by nonpharmaceutical interventions.
    Science. 2020 Jul 21. pii: science.abc9004. doi: 10.1126/science.abc9004.
    >> Share

  467. THOMS M, Buschauer R, Ameismeier M, Koepke L, et al
    Structural basis for translational shutdown and immune evasion by the Nsp1 protein of SARS-CoV-2.
    Science. 2020 Jul 17. pii: science.abc8665. doi: 10.1126/science.abc8665.
    >> Share

  468. RUKTANONCHAI NW, Floyd JR, Lai S, Ruktanonchai CW, et al
    Assessing the impact of coordinated COVID-19 exit strategies across Europe.
    Science. 2020 Jul 17. pii: science.abc5096. doi: 10.1126/science.abc5096.
    >> Share

  469. LESHNER AI
    Restart science stronger after COVID-19.
    Science. 2020;369:262.
    >> Share

  470. GUHA-SAPIR D, Moitinho de Almeida M, Keita M, Greenough G, et al
    COVID-19 policies: Remember measles.
    Science. 2020;369:261.
    >> Share

  471. AKBAR AN, Gilroy DW
    Aging immunity may exacerbate COVID-19.
    Science. 2020;369:256-257.
    >> Share

  472. KUPFERSCHMIDT K
    The pandemic virus is slowly mutating. But does it matter?
    Science. 2020;369:238-239.
    >> Share

  473. MATHEW D, Giles JR, Baxter AE, Oldridge DA, et al
    Deep immune profiling of COVID-19 patients reveals distinct immunotypes with therapeutic implications.
    Science. 2020 Jul 15. pii: science.abc8511. doi: 10.1126/science.abc8511.
    >> Share

  474. HADJADJ J, Yatim N, Barnabei L, Corneau A, et al
    Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients.
    Science. 2020 Jul 13. pii: science.abc6027. doi: 10.1126/science.abc6027.
    >> Share

  475. YUAN M, Liu H, Wu NC, Lee CD, et al
    Structural basis of a shared antibody response to SARS-CoV-2.
    Science. 2020 Jul 13. pii: science.abd2321. doi: 10.1126/science.abd2321.
    >> Share

  476. WADMAN M
    Can interferons stop COVID-19 before it takes hold?
    Science. 2020;369:125-126.
    >> Share

  477. SHAH SK, Miller FG, Darton TC, Duenas D, et al
    Unnecessary hesitancy on human vaccine tests-Response.
    Science. 2020;369:151.
    >> Share

  478. EYAL N
    Unnecessary hesitancy on human vaccine tests.
    Science. 2020;369:150-151.
    >> Share

  479. WATSA M
    Rigorous wildlife disease surveillance.
    Science. 2020;369:145-147.
    >> Share

  480. KUPFERSCHMIDT K
    U.K. megatrial outshines other drug studies.
    Science. 2020;369:124-125.
    >> Share

  481. PARIKH S
    Immigrants help make America great.
    Science. 2020;369:120.
    >> Share

  482. SILVER RC
    Surviving the trauma of COVID-19.
    Science. 2020;369:11.
    >> Share

  483. FLIES AS
    Rewilding immunology.
    Science. 2020;369:37-38.
    >> Share

  484. COHEN J
    The line starts to form for a coronavirus vaccine.
    Science. 2020;369:15-16.
    >> Share

  485. CORNWALL W
    Officials gird for a war on vaccine misinformation.
    Science. 2020;369:14-15.
    >> Share

  486. DENG W, Bao L, Liu J, Xiao C, et al
    Primary exposure to SARS-CoV-2 protects against reinfection in rhesus macaques.
    Science. 2020 Jul 2. pii: science.abc5343. doi: 10.1126/science.abc5343.
    >> Share

    June 2020

  487. Erratum for the Report: "Estimating the burden of SARS-CoV-2 in France," by H. Salje, C. Tran Kiem, N. Lefrancq, N. Courtejoie, P. Bosetti, J. Paireau, A. Andronico, N. Hoze, J. Richet, C.-L. Dubost, Y. Le Strat, J. Lessler, D. Levy-Bruhl, A. Fontanet
    Science. 2020;368.
    >> Share

  488. YOU S, Sonne C, Ok YS
    COVID-19's unsustainable waste management.
    Science. 2020;368:1438.
    >> Share

  489. HU JC
    Online GRE test heightens equity concerns.
    Science. 2020;368:1414.
    >> Share

  490. BAZELL R
    Could a blood 'observatory' stop pandemics?
    Science. 2020;368:1413.
    >> Share

  491. CAHAN E
    Charities that fund research face deep revenue declines.
    Science. 2020;368:1412.
    >> Share

  492. BRITTON T, Ball F, Trapman P
    A mathematical model reveals the influence of population heterogeneity on herd immunity to SARS-CoV-2.
    Science. 2020 Jun 23. pii: science.abc6810. doi: 10.1126/science.abc6810.
    >> Share

  493. CHI X, Yan R, Zhang J, Zhang G, et al
    A neutralizing human antibody binds to the N-terminal domain of the Spike protein of SARS-CoV-2.
    Science. 2020 Jun 22. pii: science.abc6952. doi: 10.1126/science.abc6952.
    >> Share

  494. SHARPLESS NE
    COVID-19 and cancer.
    Science. 2020;368:1290.
    >> Share

  495. MERVIS J
    U.S. academic research funding stays healthy despite pandemic.
    Science. 2020;368:1298.
    >> Share

  496. SERVICK K
    Can phone apps slow the spread of the coronavirus?
    Science. 2020;368:1296-1297.
    >> Share

  497. COHEN J
    Pandemic vaccines are about to face the real test.
    Science. 2020;368:1295-1296.
    >> Share

  498. LE T, Wang Y, Liu L, Yang J, et al
    Unexpected air pollution with marked emission reductions during the COVID-19 outbreak in China.
    Science. 2020 Jun 17. pii: science.abb7431. doi: 10.1126/science.abb7431.
    >> Share

  499. BAUM A, Fulton BO, Wloga E, Copin R, et al
    Antibody cocktail to SARS-CoV-2 spike protein prevents rapid mutational escape seen with individual antibodies.
    Science. 2020 Jun 15. pii: science.abd0831. doi: 10.1126/science.abd0831.
    >> Share

  500. ROGERS TF, Zhao F, Huang D, Beutler N, et al
    Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model.
    Science. 2020 Jun 15. pii: science.abc7520. doi: 10.1126/science.abc7520.
    >> Share

  501. BROUWER PJM, Caniels TG, van der Straten K, Snitselaar JL, et al
    Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability.
    Science. 2020 Jun 15. pii: science.abc5902. doi: 10.1126/science.abc5902.
    >> Share

  502. HANSEN J, Baum A, Pascal KE, Russo V, et al
    Studies in humanized mice and convalescent humans yield a SARS-CoV-2 antibody cocktail.
    Science. 2020 Jun 15. pii: science.abd0827. doi: 10.1126/science.abd0827.
    >> Share

  503. WEC AZ, Wrapp D, Herbert AS, Maurer DP, et al
    Broad neutralization of SARS-related viruses by human monoclonal antibodies.
    Science. 2020 Jun 15. pii: science.abc7424. doi: 10.1126/science.abc7424.
    >> Share

  504. OGBURN EL, Bierer BE, Brookmeyer R, Choirat C, et al
    Aggregating data from COVID-19 trials.
    Science. 2020;368:1198-1199.
    >> Share

  505. CHUMAKOV K, Benn CS, Aaby P, Kottilil S, et al
    Can existing live vaccines prevent COVID-19?
    Science. 2020;368:1187-1188.
    >> Share

  506. BELONGIA EA, Osterholm MT
    COVID-19 and flu, a perfect storm.
    Science. 2020;368:1163.
    >> Share

  507. WALKER PGT, Whittaker C, Watson OJ, Baguelin M, et al
    The impact of COVID-19 and strategies for mitigation and suppression in low- and middle-income countries.
    Science. 2020 Jun 12. pii: science.abc0035. doi: 10.1126/science.abc0035.
    >> Share

  508. GONCALVES PR, Di Dario F, Petry AC, Martins RL, et al
    Brazil undermines parks by relocating staff.
    Science. 2020;368:1199.
    >> Share

  509. WADMAN M
    Vaccines that use human fetal cells draw fire.
    Science. 2020;368:1170-1171.
    >> Share

  510. ENSERINK M
    Coronavirus rips through Dutch mink farms, triggering culls.
    Science. 2020;368:1169.
    >> Share

  511. PILLER C, Travis J
    Authors, elite journals under fire after major retractions.
    Science. 2020;368:1167-1168.
    >> Share

  512. KUPFERSCHMIDT K
    Big studies dim hopes for hydroxychloroquine.
    Science. 2020;368:1166-1167.
    >> Share

  513. THORP HH
    Time to look in the mirror.
    Science. 2020;368:1161.
    >> Share

  514. MAJOR J, Crotta S, Llorian M, McCabe TM, et al
    Type I and III interferons disrupt lung epithelial repair during recovery from viral infection.
    Science. 2020 Jun 11. pii: science.abc2061. doi: 10.1126/science.abc2061.
    >> Share

  515. BROGGI A, Ghosh S, Sposito B, Spreafico R, et al
    Type III interferons disrupt the lung epithelial barrier upon viral recognition.
    Science. 2020 Jun 11. pii: science.abc3545. doi: 10.1126/science.abc3545.
    >> Share

  516. DENG X, Gu W, Federman S, du Plessis L, et al
    Genomic surveillance reveals multiple introductions of SARS-CoV-2 into Northern California.
    Science. 2020 Jun 8. pii: science.abb9263. doi: 10.1126/science.abb9263.
    >> Share

  517. HTUN M
    Tenure and promotion after the pandemic.
    Science. 2020;368:1075.
    >> Share

  518. PENNISI E
    Shuttered natural history museums fight for survival.
    Science. 2020;368:1042-1043.
    >> Share

  519. SERVICK K, Enserink M
    The pandemic's first major research scandal erupts.
    Science. 2020;368:1041-1042.
    >> Share

  520. MATACIC C
    Blood vessel injury may spur disease's fatal second phase.
    Science. 2020;368:1039-1040.
    >> Share

  521. WADMAN M
    Sex hormones signal why virus hits men harder.
    Science. 2020;368:1038-1039.
    >> Share

  522. ZERHOUNI W, Nabel GJ, Zerhouni E
    Patents, economics, and pandemics.
    Science. 2020;368:1035.
    >> Share

  523. HAUSHOFER J, Metcalf CJE
    Which interventions work best in a pandemic?
    Science. 2020;368:1063-1065.
    >> Share

    May 2020
  524. AHMED MA, Behbahani AH, Bruckner A, Charpentier CJ, et al
    The precarious position of postdocs during COVID-19.
    Science. 2020;368:957-958.
    >> Share

  525. LAKDAWALA SS, Menachery VD
    The search for a COVID-19 animal model.
    Science. 2020;368:942-943.
    >> Share

  526. BEKKER LG, Mizrahi V
    COVID-19 research in Africa.
    Science. 2020;368:919.
    >> Share

  527. GONZALEZ-REICHE AS, Hernandez MM, Sullivan MJ, Ciferri B, et al
    Introductions and early spread of SARS-CoV-2 in the New York City area.
    Science. 2020 May 29. pii: science.abc1917. doi: 10.1126/science.abc1917.
    >> Share

  528. VASAVDA C, Ho BK, Snyder SH
    Ease restrictions on U.S. blood donations.
    Science. 2020;368:957.
    >> Share

  529. WADMAN M
    Sick chinchillas languish at farms that supply researchers.
    Science. 2020;368:928.
    >> Share

  530. BRAINARD J
    New tools aim to tame pandemic paper tsunami.
    Science. 2020;368:924-925.
    >> Share

  531. COUZIN-FRANKEL J
    Doctors race to understand inflammatory condition in kids.
    Science. 2020;368:923-924.
    >> Share

  532. KUPFERSCHMIDT K
    Scientists put survivors' blood plasma to the test.
    Science. 2020;368:922-923.
    >> Share

  533. MELLO MM, Wang CJ
    Ethics and governance for digital disease surveillance.
    Science. 2020;368:951-954.
    >> Share

  534. WIGGINTON NS, Cunningham RM, Katz RH, Lidstrom ME, et al
    Moving academic research forward during COVID-19.
    Science. 2020 May 28. pii: science.abc5599. doi: 10.1126/science.abc5599.
    >> Share

  535. PRATHER KA, Wang CC, Schooley RT
    Reducing transmission of SARS-CoV-2.
    Science. 2020 May 27. pii: science.abc6197. doi: 10.1126/science.abc6197.
    >> Share

  536. GUY RK, DiPaola RS, Romanelli F, Dutch RE, et al
    Rapid repurposing of drugs for COVID-19.
    Science. 2020;368:829-830.
    >> Share

  537. JANKOWSKI M, Mozdziak P, Kempisty B
    COVID-19 spotlights medical diagnostics.
    Science. 2020;368:839.
    >> Share

  538. PEARSON RM, Sievers M, McClure EC, Turschwell MP, et al
    COVID-19 recovery can benefit biodiversity.
    Science. 2020;368:838-839.
    >> Share

  539. CHO A
    AI systems aim to sniff out coronavirus outbreaks.
    Science. 2020;368:810-811.
    >> Share

  540. LESLIE M
    T cells found in coronavirus patients 'bode well' for long-term immunity.
    Science. 2020;368:809-810.
    >> Share

  541. KUPFERSCHMIDT K
    Case clustering emerges as key pandemic puzzle.
    Science. 2020;368:808-809.
    >> Share

  542. COHEN J
    Long-acting drug acts like a short-term AIDS vaccine.
    Science. 2020;368:807.
    >> Share

  543. THORP HH
    Suspend tests and rankings.
    Science. 2020;368:797.
    >> Share

  544. CHANDRASHEKAR A, Liu J, Martinot AJ, McMahan K, et al
    SARS-CoV-2 infection protects against rechallenge in rhesus macaques.
    Science. 2020 May 20. pii: science.abc4776. doi: 10.1126/science.abc4776.
    >> Share

  545. YU J, Tostanoski LH, Peter L, Mercado NB, et al
    DNA vaccine protection against SARS-CoV-2 in rhesus macaques.
    Science. 2020 May 20. pii: science.abc6284. doi: 10.1126/science.abc6284.
    >> Share

  546. BAKER RE, Yang W, Vecchi GA, Metcalf CJE, et al
    Susceptible supply limits the role of climate in the early SARS-CoV-2 pandemic.
    Science. 2020 May 18. pii: science.abc2535. doi: 10.1126/science.abc2535.
    >> Share

  547. STANISCUASKI F, Reichert F, Werneck FP, de Oliveira L, et al
    Impact of COVID-19 on academic mothers.
    Science. 2020;368:724.
    >> Share

  548. KRAMMER F, Simon V
    Serology assays to manage COVID-19.
    Science. 2020 May 15. pii: science.abc1227. doi: 10.1126/science.abc1227.
    >> Share

  549. DEHNING J, Zierenberg J, Spitzner FP, Wibral M, et al
    Inferring change points in the spread of COVID-19 reveals the effectiveness of interventions.
    Science. 2020 May 15. pii: science.abb9789. doi: 10.1126/science.abb9789.
    >> Share

  550. REIDPATH D, Allotey P
    Preserve Global South's research capacity.
    Science. 2020;368:725.
    >> Share

  551. ROURKE M, Eccleston-Turner M, Phelan A, Gostin L, et al
    Policy opportunities to enhance sharing for pandemic research.
    Science. 2020;368:716-718.
    >> Share

  552. WADMAN M
    Antivaccine forces gaining online.
    Science. 2020;368:699.
    >> Share

  553. SERVICK K
    Pandemic could add noise to clinical trial data.
    Science. 2020;368:693.
    >> Share

  554. COHEN J
    U.S. 'Warp Speed' vaccine effort comes out of the shadows.
    Science. 2020;368:692-693.
    >> Share

  555. GRIMM D
    As labs move to reopen, safety worries abound.
    Science. 2020;368:690-691.
    >> Share

  556. MCNUTT M
    Lessons from the crucible of crisis.
    Science. 2020;368:683.
    >> Share

  557. THORP HH
    Both/and problem in an either/or world.
    Science. 2020;368:681.
    >> Share

  558. WU Y, Wang F, Shen C, Peng W, et al
    A noncompeting pair of human neutralizing antibodies block COVID-19 virus binding to its receptor ACE2.
    Science. 2020 May 13. pii: science.abc2241. doi: 10.1126/science.abc2241.
    >> Share

  559. SALJE H, Tran Kiem C, Lefrancq N, Courtejoie N, et al
    Estimating the burden of SARS-CoV-2 in France.
    Science. 2020 May 13. pii: science.abc3517. doi: 10.1126/science.abc3517.
    >> Share

  560. COREY BL, Mascola JR, Fauci AS, Collins FS, et al
    A strategic approach to COVID-19 vaccine R&D.
    Science. 2020 May 11. pii: science.abc5312. doi: 10.1126/science.abc5312.
    >> Share

  561. AZOULAY P, Jones B
    Beat COVID-19 through innovation.
    Science. 2020;368:553.
    >> Share

  562. COHEN MS, Corey L
    Combination prevention for COVID-19.
    Science. 2020;368:551.
    >> Share

  563. GRAHAM BS
    Rapid COVID-19 vaccine development.
    Science. 2020 May 8. pii: science.abb8923. doi: 10.1126/science.abb8923.
    >> Share

  564. FIKRIG K
    A Ph.D. on hold-indefinitely.
    Science. 2020;368:674.
    >> Share

  565. GIBBONS A
    Ape researchers mobilize to save primates from coronavirus.
    Science. 2020;368:566.
    >> Share

  566. COHEN J
    The race is on for antibodies that stop the new coronavirus.
    Science. 2020;368:564-565.
    >> Share

  567. VOGEL G, Couzin-Frankel J
    Children's role in pandemic is still a puzzle.
    Science. 2020;368:562-563.
    >> Share

  568. WADMAN M, Cohen J
    NIH move to ax bat coronavirus grant draws fire.
    Science. 2020;368:561-562.
    >> Share

  569. YUAN M, Wu NC, Zhu X, Lee CD, et al
    A highly conserved cryptic epitope in the receptor binding domains of SARS-CoV-2 and SARS-CoV.
    Science. 2020;368:630-633.
    >> Share

  570. SHEA K, Runge MC, Pannell D, Probert WJM, et al
    Harnessing multiple models for outbreak management.
    Science. 2020;368:577-579.
    >> Share

  571. SARASWAT R, Saraswat DA
    Research opportunities in pandemic lockdown.
    Science. 2020;368:594-595.
    >> Share

  572. SHAH SK, Miller FG, Darton TC, Duenas D, et al
    Ethics of controlled human infection to study COVID-19.
    Science. 2020 May 7. pii: science.abc1076. doi: 10.1126/science.abc1076.
    >> Share

  573. GAO Q, Bao L, Mao H, Wang L, et al
    Rapid development of an inactivated vaccine candidate for SARS-CoV-2.
    Science. 2020 May 6. pii: science.abc1932. doi: 10.1126/science.abc1932.
    >> Share

  574. DREW DA, Nguyen LH, Steves CJ, Menni C, et al
    Rapid implementation of mobile technology for real-time epidemiology of COVID-19.
    Science. 2020 May 5. pii: science.abc0473. doi: 10.1126/science.abc0473.
    >> Share

  575. WATANABE Y, Allen JD, Wrapp D, McLellan JS, et al
    Site-specific glycan analysis of the SARS-CoV-2 spike.
    Science. 2020 May 4. pii: science.abb9983. doi: 10.1126/science.abb9983.
    >> Share

  576. BARTON CM, Alberti M, Ames D, Atkinson JA, et al
    Call for transparency of COVID-19 models.
    Science. 2020;368:482-483.
    >> Share

  577. COHEN J
    COVID-19 shot protects monkeys.
    Science. 2020;368:456-457.
    >> Share

  578. ROSENBLOOM D, Markard J
    A COVID-19 recovery for climate.
    Science. 2020;368:447.
    >> Share

  579. DITEKEMENA J
    COVID-19 amidst Ebola's retreat.
    Science. 2020;368:445.
    >> Share

  580. YIN W, Mao C, Luan X, Shen DD, et al
    Structural basis for inhibition of the RNA-dependent RNA polymerase from SARS-CoV-2 by remdesivir.
    Science. 2020 May 1. pii: science.abc1560. doi: 10.1126/science.abc1560.
    >> Share

  581. LAMERS MM, Beumer J, van der Vaart J, Knoops K, et al
    SARS-CoV-2 productively infects human gut enterocytes.
    Science. 2020 May 1. pii: science.abc1669. doi: 10.1126/science.abc1669.
    >> Share

  582. KUPFERSCHMIDT K
    The coronavirus czar.
    Science. 2020;368:462-465.
    >> Share

  583. PRICE M
    Scientists discover upsides of virtual meetings.
    Science. 2020;368:457-458.
    >> Share

  584. COUZIN-FRANKEL J
    The mystery of the pandemic's 'happy hypoxia'.
    Science. 2020;368:455-456.
    >> Share

  585. LONDON AJ, Kimmelman J
    Against pandemic research exceptionalism.
    Science. 2020;368:476-477.
    >> Share

  586. KRAEMER MUG, Yang CH, Gutierrez B, Wu CH, et al
    The effect of human mobility and control measures on the COVID-19 epidemic in China.
    Science. 2020;368:493-497.
    >> Share

  587. LI R, Pei S, Chen B, Song Y, et al
    Substantial undocumented infection facilitates the rapid dissemination of novel coronavirus (SARS-CoV-2).
    Science. 2020;368:489-493.
    >> Share

    April 2020
  588. ZHANG J, Litvinova M, Liang Y, Wang Y, et al
    Changes in contact patterns shape the dynamics of the COVID-19 outbreak in China.
    Science. 2020 Apr 29. pii: science.abb8001. doi: 10.1126/science.abb8001.
    >> Share

  589. COBEY S
    Modeling infectious disease dynamics.
    Science. 2020 Apr 24. pii: science.abb5659. doi: 10.1126/science.abb5659.
    >> Share

  590. KONG J, Chan S
    Advice for the worried.
    Science. 2020;368:438.
    >> Share

  591. SERVICK K
    Survivors' burden.
    Science. 2020;368:359.
    >> Share

  592. WADMAN M, Couzin-Frankel J, Kaiser J, Matacic C, et al
    A rampage through the body.
    Science. 2020;368:356-360.
    >> Share

  593. AMIGO I
    Indigenous communities in Brazil fear pandemic's impact.
    Science. 2020;368:352.
    >> Share

  594. KAISER J
    NIH organizes hunt for drugs.
    Science. 2020;368:351.
    >> Share

  595. VOGEL G
    First antibody surveys draw fire for quality, bias.
    Science. 2020;368:350-351.
    >> Share

  596. NEWLAND K
    Lost in transition.
    Science. 2020;368:343.
    >> Share

  597. THORP HH
    Why WHO?
    Science. 2020;368:341.
    >> Share

  598. DAI W, Zhang B, Su H, Li J, et al
    Structure-based design of antiviral drug candidates targeting the SARS-CoV-2 main protease.
    Science. 2020 Apr 22. pii: science.abb4489. doi: 10.1126/science.abb4489.
    >> Share

  599. MOORE BJB, June CH
    Cytokine release syndrome in severe COVID-19.
    Science. 2020 Apr 17. pii: science.abb8925. doi: 10.1126/science.abb8925.
    >> Share

  600. ROCKX B, Kuiken T, Herfst S, Bestebroer T, et al
    Comparative pathogenesis of COVID-19, MERS, and SARS in a nonhuman primate model.
    Science. 2020 Apr 17. pii: science.abb7314. doi: 10.1126/science.abb7314.
    >> Share

  601. FERRANTE L, Fearnside PM
    Protect Indigenous peoples from COVID-19.
    Science. 2020;368:251.
    >> Share

  602. WALLACE N
    Top EU scientist ousted over plans for coronavirus research.
    Science. 2020;368:223.
    >> Share

  603. COHEN J
    From mice to monkeys, animals studied for coronavirus answers.
    Science. 2020;368:221-222.
    >> Share

  604. PENNISI E
    Pandemic carves gaps in long-term field projects.
    Science. 2020;368:220-221.
    >> Share

  605. KUPFERSCHMIDT K
    The lockdowns worked-but what comes next?
    Science. 2020;368:218-219.
    >> Share

  606. VON BRAUN J, Zamagni S, Sorondo MS
    The moment to see the poor.
    Science. 2020;368:214.
    >> Share

  607. KISSLER SM, Tedijanto C, Goldstein E, Grad YH, et al
    Projecting the transmission dynamics of SARS-CoV-2 through the postpandemic period.
    Science. 2020 Apr 14. pii: science.abb5793. doi: 10.1126/science.abb5793.
    >> Share

  608. GAO Y, Yan L, Huang Y, Liu F, et al
    Structure of the RNA-dependent RNA polymerase from COVID-19 virus.
    Science. 2020 Apr 10. pii: science.abb7498. doi: 10.1126/science.abb7498.
    >> Share

  609. ATKINSON C
    G20 leaders must answer to COVID-19.
    Science. 2020;368:111.
    >> Share

  610. SHI J, Wen Z, Zhong G, Yang H, et al
    Susceptibility of ferrets, cats, dogs, and other domesticated animals to SARS-coronavirus 2.
    Science. 2020 Apr 8. pii: science.abb7015. doi: 10.1126/science.abb7015.
    >> Share

  611. MAIER BF, Brockmann D
    Effective containment explains subexponential growth in recent confirmed COVID-19 cases in China.
    Science. 2020 Apr 8. pii: science.abb4557. doi: 10.1126/science.abb4557.
    >> Share

  612. ZHOU Y
    Making allowances for COVID-19.
    Science. 2020;368:98.
    >> Share

  613. NORMILE D
    As normalcy returns, can China keep COVID-19 at bay?
    Science. 2020;368:18-19.
    >> Share

  614. COHEN J
    Vaccine designers take first shots at COVID-19.
    Science. 2020;368:14-16.
    >> Share

    March 2020
  615. FERRETTI L, Wymant C, Kendall M, Zhao L, et al
    Quantifying SARS-CoV-2 transmission suggests epidemic control with digital contact tracing.
    Science. 2020 Mar 31. pii: science.abb6936. doi: 10.1126/science.abb6936.
    >> Share

  616. TIAN H, Liu Y, Li Y, Wu CH, et al
    An investigation of transmission control measures during the first 50 days of the COVID-19 epidemic in China.
    Science. 2020 Mar 31. pii: science.abb6105. doi: 10.1126/science.abb6105.
    >> Share

  617. BUCKEE CO, Balsari S, Chan J, Crosas M, et al
    Aggregated mobility data could help fight COVID-19.
    Science. 2020 Mar 23. pii: science.abb8021. doi: 10.1126/science.abb8021.
    >> Share

  618. FITZGERALD GA
    Misguided drug advice for COVID-19.
    Science. 2020 Mar 20. pii: science.abb8034. doi: 10.1126/science.abb8034.
    >> Share

  619. ZHANG L, Lin D, Sun X, Curth U, et al
    Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved alpha-ketoamide inhibitors.
    Science. 2020 Mar 20. pii: science.abb3405. doi: 10.1126/science.abb3405.
    >> Share

  620. LIU K
    How I faced my coronavirus anxiety.
    Science. 2020;367:1398.
    >> Share

  621. RZYMSKI P, Nowicki M
    Preventing COVID-19 prejudice in academia.
    Science. 2020;367:1313.
    >> Share

  622. COHEN J
    Sick time.
    Science. 2020;367:1294-1297.
    >> Share

  623. SERVICK K, Cho A, Couzin-Frankel J, Guglielmi G, et al
    Coronavirus disruptions reverberate through research.
    Science. 2020;367:1289-1290.
    >> Share

  624. COHEN J, Kupferschmidt K
    Countries test tactics in 'war' against COVID-19.
    Science. 2020;367:1287-1288.
    >> Share

  625. THORP HH
    Time to pull together.
    Science. 2020;367:1282.
    >> Share

  626. KUPFERSCHMIDT K, Cohen J
    Can China's COVID-19 strategy work elsewhere?
    Science. 2020;367:1061-1062.
    >> Share

  627. CHINAZZI M, Davis JT, Ajelli M, Gioannini C, et al
    The effect of travel restrictions on the spread of the 2019 novel coronavirus (COVID-19) outbreak.
    Science. 2020 Mar 6. pii: science.aba9757. doi: 10.1126/science.aba9757.
    >> Share

  628. YAN R, Zhang Y, Li Y, Xia L, et al
    Structural basis for the recognition of the SARS-CoV-2 by full-length human ACE2.
    Science. 2020 Mar 4. pii: science.abb2762. doi: 10.1126/science.abb2762.
    >> Share

    February 2020
  629. THORP HH
    The costs of secrecy.
    Science. 2020;367:959.
    >> Share

  630. WRAPP D, Wang N, Corbett KS, Goldsmith JA, et al
    Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation.
    Science. 2020 Feb 19. pii: science.abb2507. doi: 10.1126/science.abb2507.
    >> Share

    January 2020
  631. COHEN J, Normile D
    New SARS-like virus in China triggers alarm.
    Science. 2020;367:234-235.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016